A Phenomenological Study of Methadone Treatment by Opiate-Dependent Individuals Ages 50-55 Years by Hightower, LaMart
Walden University
ScholarWorks
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral StudiesCollection
2016
A Phenomenological Study of Methadone




Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Social Work Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been



















has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  




Dr. Barbara Benoliel, Committee Chairperson, Human Services Faculty 
Dr. Jason Patton, Committee Member, Human Services Faculty 






Chief Academic Officer 













 A Phenomenological Study of Methadone Treatment by Opiate-Dependent Individuals 




MSW, Western Michigan University, 1985 
BS, Western Michigan University, 1978 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 









Today’s methadone patients differ from those of the past due to increases in polydrug 
use, mental health issues, and medical needs. Patients requiring methadone treatment for 
their opiate addiction are now older than those who initially presented for treatment when 
methadone treatment first started. The number of older opiate users will continue to grow 
as the population continues to age. Although previous studies on opiate addiction focused 
on using methadone in treatment of younger adults, this study used phenomenological 
methodology to explore the lived experiences of opiate addicted methadone users 
between the ages of 50 to 55, an understudied population. A sample of 8 older addicts from 
the Midwest, using methadone in their treatment, provided data collected in face-to-face 
interviews for this study. Content analysis of the data was conducted with the assistance of 
NVivo 11 to code and identify categories and themes. Emergent themes included: the 
impact of methadone use on participants’ relationship with others, participants’ attitude 
of being an older methadone user, mental health stressors related to being an older 
methadone user, struggles in attending the methadone clinic daily, and needing other 
treatment besides treatment for methadone use. The study impacts social change by 
informing addiction professionals who may want to develop appropriate treatment 







A Phenomenological Study of Methadone Treatment by Opiate-Dependent Individuals 




MSW, Western Michigan University, 1985 
BS, Western Michigan University, 1978 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 









This dissertation is dedicated to my Lord and Savior Jesus Christ. Through him all 
things are possible.  To Oscar and Robin, thank you both for teaching me about what you 






















I want to thank everyone who helped, inspired, encouraged me, but more importantly 
stood by me throughout my doctoral journey. To my late parents Dorothy and William.  
You instilled in me the importance of getting an education. To the love of my life, Nancy, 
you are the wind beneath my wings. To my children, William and Elizabeth. I am proud 
of the adults you have become. To my friends and brothers at the Jellema House, Derrick 
and Johnny. I appreciate you more than you will ever know. To my colleagues at the 
Southwest Clinic. Thank you for your prayers and encouragement telling me that I can do 
it. To my Oakdale CRC family. Your prayers lifted me up and helped me keep my eye on 
the prize. To two very special people, Veneese and Bernice. To Danielle Hopwood, my 
transcriptionist and data interpreter. You helped me interpret what I learned. I always felt 
your prayers and heard your words of encouragement. To my academic advisor, Joe 
Underwood. You helped me navigate some choppy waters. To my supervising committee 
members, Dr. Barbara Benoliel (chairperson and context expert) for her consistent 
thoroughness, rigorous guidance, strong support, and tireless persistence. Dr. Jason 
Patton (methodologist) for his steadfast brilliance, kind understanding, and most 
importantly, for his accurate and reliable assistance. Dr. James Castleberry (university 
research reviewer) for his hard work, genuine cooperation, and unwavering support 
throughout the entire dissertation process. I want to express my deepest appreciation to 
the professional guidance and able direction provided by the Walden family. You made 
my dissertation stronger. I also thank you for being there when I needed you. To my 
editor, Sonia Castleberry. Thank you for getting me across the finish line. Finally, I want 
 
 
to profoundly thank all the participants in this study for their willingness to share their 










Table of Contents 
List of Tables ..................................................................................................................... vi 
List of Figures ................................................................................................................... vii 
Chapter 1: Introduction to the Study ................................................................................... 1 
Purpose of the Study ..................................................................................................... 5 
Significance of the Study .............................................................................................. 6 
Problem Statement ........................................................................................................ 8 
Research Questions ....................................................................................................... 9 
Conceptual Framework ................................................................................................. 9 
Nature of the Study ..................................................................................................... 12 
Definitions................................................................................................................... 12 
Assumptions and Limitations ..................................................................................... 17 
Summary and Organization of the Study .................................................................... 18 
Chapter 2: Literature Review ............................................................................................ 20 
Literature Search Strategy........................................................................................... 20 
Introduction to the Literature Review ......................................................................... 21 
Definition of Dependency and/or Abuse .................................................................... 22 
Definition of Opiates................................................................................................... 24 
Oxycodone ............................................................................................................ 24 
Heroin ................................................................................................................... 25 
Harm Reduction .......................................................................................................... 26 




Drugs Used to Manage Opiate Addiction ................................................................... 28 
Methadone............................................................................................................. 28 
Buprenorphine....................................................................................................... 29 
Naloxone ............................................................................................................... 30 
Nondrug Treatment for Opiate Addiction................................................................... 30 
Problems Associated With Opiate Use ....................................................................... 33 
Pain Management........................................................................................................ 33 
Dangers of Opiate Drugs ............................................................................................ 34 
Illegal Drug Use .......................................................................................................... 36 
Addiction and HIV ................................................................................................ 37 
Sexual Behaviors in Addiction ............................................................................. 37 
Mortality From Addiction ........................................................................................... 38 
Psychiatric Problems in Addiction.............................................................................. 40 
Medical Problems Associated With Opiate Addiction ............................................... 41 
Criminal Behavior Associated With Opiate Addiction .............................................. 42 
Cravings for Opiate Drugs .......................................................................................... 43 
Barriers to Treatment for Opiate Addiction ................................................................ 45 
Older Addicts .............................................................................................................. 46 
Summary....……..........................................................................................................48 
Chapter 3: Research Method ............................................................................................. 50 





The Heuristic Approach .............................................................................................. 52 
Research Questions ..................................................................................................... 54 
      Informed Consent Process…..……………………………………………………….54 
 
      Participants…………………………………………………………………………...55 
 
Sampling Method ........................................................................................................ 56 
Participant Recruitment .............................................................................................. 57 
Research Procedure ..................................................................................................... 59 
Data Collection: Individual Interviews ................................................................. 59 
Initial Data Collection: Background Questionnaires and In-Depth Interviewing 59 
Interview Procedures .................................................................................................. 61 
Researcher’s Role ....................................................................................................... 62 
Transcript Preparation ................................................................................................. 63 
Data Analysis .............................................................................................................. 64 
Themes ........................................................................................................................ 65 
Bracketing ................................................................................................................... 66 
Establishing Credibility of Qualitative Data ............................................................... 67 
Immersion ............................................................................................................. 67 
Member Checks .................................................................................................... 67 
Research Auditor .................................................................................................. 68 
Transferability ....................................................................................................... 69 
Triangulation ......................................................................................................... 69 




Summary ..................................................................................................................... 71 
Chapter 4:Results………………………………………………………………………...72 
 
Participant Profiles ...................................................................................................... 73 
Nancy .................................................................................................................... 74 
William ................................................................................................................. 75 
Elizabeth ............................................................................................................... 76 
Danny .................................................................................................................... 76 
Anna ...................................................................................................................... 77 
Bernice .................................................................................................................. 78 
Rex ........................................................................................................................ 79 
James ..................................................................................................................... 80 
Themes Derived From Data Analysis ......................................................................... 80 
Methadone’s Impact on Participants’ Relationships with Others ......................... 83 
Attitudes Related to Being an Older Methadone User.......................................... 86 
Mental Health Stresses .......................................................................................... 89 
Attending the Methadone Clinic Daily ................................................................. 92 
Needing Other Treatment Besides Methadone ..................................................... 95 
Summary……………………………………………………………………………..97 
      Chapter 5: Discussion, Conclusions, and Recommendations ..................................... 98 
Hermeneutic Reflection ............................................................................................ 100 
Research Questions and Answers ............................................................................. 100 




Research Question 2 ........................................................................................... 101 
            Follow-Up Question…………………………………………………………….102 
 
Thematic Findings .................................................................................................... 103 
Theme 1: Methadone Impact on Participants’ Relationships With Others ......... 103 
Theme 2: Attitude of Being an Older Methadone User ...................................... 105 
Theme 3: Mental Health Stresses ....................................................................... 106 
Theme 4: Attending the Methadone Clinic Daily ............................................... 108 
Theme 5: Needing Other Treatment Besides Methadone ................................... 109 
      Limitations of the Study…………………………………………………………….112 
 
Research Recommendations ..................................................................................... 114 
Implications for Social Change ................................................................................. 117 
Conclusion ................................................................................................................ 119 
References ....................................................................................................................... 121 
Appendix A: Advertisement for Potential Participants ................................................ 1664 
Appendix B: Demographic Data Questionnaire ........................................................... 1696 
Appendix C: Informed Consent .................................................................................. 17469 





List of Tables 
Table 1. Participant Demographics ................................................................................... 73 
Table 2. Participants’ Treatment History .......................................................................... 74 
Table 3. Final Themes With NVivo 11 Data Analysis Summary Demographics of  





List of Figures 
 
Figure 1. Opiate users by age, 2002–2012 ...........................................................................2 
 
Figure 2.  Rates of death associated with heroin and prescription opioids,  










Chapter 1: Introduction to the Study 
Drug addiction is increasing in the United States. According to the National 
Institute on Drug Abuse (2011), in 2010 more than 23,000,000 Americans age 12 years 
and older had used some type of illicit drug or abused psychotherapeutic medication. 
According to the Substance Abuse and Mental Health Services Administration 
(SAMHSA, 2014), illicit drug use in older adults increased 3.4% in 2002 to 7.9% in 
2013. Among individuals ages 55–59 years, the rate of current illicit drug use increased 
from 1.9% in 2002 to 5.7% in 2013. Among individuals ages 60–64 years, the rate of 
current illicit drug use increased from 1.1% in 2003 and 2004 to 3.9% in 2013 
(SAMHSA, 2014).  
Opiate dependency is becoming a major issue. From 2000 to 2010, opiate use and 
dependency nearly tripled (SAMHSA, 2011). Among people ages 50–59 years, the rate 
of illicit drug use including opiates went from 2.7% in 2002 to 5.8% in 2010 (SAMHSA, 
2011). This increase also reflects more people with an opiate addiction seeking treatment. 
Treatment admission for opiate-addicted clients increased 271% between 1995 and 2005 
(SAMHSA, 2011). Figure 1 illustrates the increase of opiate use among older adults over 





Figure 1. Opiate users by age, 2002–2012. Adapted from Results From the 2013 National 
Survey on Drug Use and Health: Summary of National Findings, by the Substance Abuse 
and Mental Health Services Administration, 2013, p. 24. Copyright 2014 by the 
Substance Abuse and Mental Health Services Administration.  
 
Many people who were addicted to drugs and alcohol are now experiencing 
successful abstinence from their addiction and are living a life of recovery. According to 
a 2007 study by National Institute on Drug Abuse, there was an 86% abstinence rate after 
3 years of recovery (National Institute on Drug Abuse, 2011). Previous research 
regarding addiction has shown that opiate addicts continue to use substances long after 
being involved in treatment despite the high death rate associated with opiate use 
(Scherbaum & Specka, 2008). However, there is a positive correlation between 
individuals taking methadone and staying in treatment. This correlation is attributed to 




The concept of recovery is sometimes unclear and difficult to define. T. McLellan 
(2012) indicated that many people, professionals, and laypersons use the term recovery, 
but there is no standard definition for the term. T. McLellan noted that in 2006, the Betty 
Ford Institute presented a working definition for recovery in order to dialogue about its 
meaning. The institute defined recovery as “A voluntarily maintained lifestyle comprised 
of sobriety, personal health, and citizenship” (Betty Ford Institute, as cited in T. 
McLellan, 2010, p. 137). This definition was consistent with experts who also saw 
recovery in the same manner (Belleau et al., 2007). 
Others have indicated that in order for addicts to be successful in their recovery, 
they must be abstinent from their drug of choice for at least 2 years (Del Toro, Thom, 
Beam, & Horst, 1996). Recovery is seen as the primary reason for treatment in most 
behavioral health care policies (Institute of Medicine, 2006). This is especially true when 
examining government-funded service initiatives, such as the Center for Substance Abuse 
Treatment’s Community Support Program and Access to Recovery Program, as well as 
community programs that work to develop recovery-oriented care (White, 2009). 
Individuals who are involved in recovery often need additional support such as a 12-step 
program or a relationship with a higher power (Laudet, 2007). De Maeyer et al. (2011) 
concluded that it was important to support opiate-addicted individuals in their daily lives 
by providing them practical, social, and environmental support in addition to their 
methadone use to improve their quality of life.  
Methadone treatment dates back more than half a century, and programs for 




clinical trial to demonstrate methadone’s effectiveness, Dole and Nyswadner developed a 
new approach to opiate addiction treatment (as cited in Kuehn, 2005). Their research 
suggested that doctors could use medications to help control addicts’ cravings and 
withdrawal, which often led to relapse in individuals with opioid addiction. Their work 
began to give credence to the idea that opioid addiction is a chronic disease, similar to 
diabetes, requiring long-term treatment. Methadone is the primary medication for treating 
heroin addiction (Mattick, Breen, Kimber, & Davoli, 2009). Addicts are given a daily 
dosage of methadone as it remains operational in their system for 24 hours, blocking 
heroin’s euphoric properties (Jaffe, 1990). Methadone continues to be the most accepted 
treatment for opiate addiction.  Under the supervision of trained medical professionals, 
methadone has been shown to provide effective treatment for people addicted to opiates 
(Amato et al., 2005).  
Although several countries use methadone for treating opioid dependence, there 
has been some discussion about its effectiveness. Methadone helps opiate addicts reduce 
their withdrawal symptoms and has been seen as a lifesaver for many people (Bart, 
2012). However, it is not an addiction cure-all. Research has shown that some addicts use 
other addicting drugs such as cocaine and benzodiazepines while engaging in other 
disruptive behaviors that affect their treatment (Kleber, 2008). Keys (2008) noted that 
there has been significant debate about the reasons addicts continue to use opiates and 
indicated that addicts seek a feeling of euphoria or they are trying to avoid the pains of 
withdrawal. When opiate addicts fail to complete treatment or have a negative attitude 




Browne, and Marsden (2002) studied relapse involving heroin users and learned that 
addicts who failed to complete treatment or had a negative attitude about methadone were 
at a greater risk of relapse than those who were successful in treatment.    
In their study on addiction, Stephens, Roffman, Fearer, Williams, and Burke, 
(2007) noted that one reason for people not seeking treatment was that they were not 
ready to stop using their drug of choice. Orr-Brown and Sibert (2007) noted that if child 
welfare or other systems order people into treatment, they are resistant to treatment if 
they do not want to change. Collins and Slesnick’s (2011) study on motivation for 
discontinuation showed that people were reluctant to change despite the consequences of 
their continued usage. Methadone has been the most studied treatment modality for 
opiate dependency, and previous studies have shown it has been effective (Clausen, 
Anchersen, & Waal, 2008; Degenhardt et al., 2011; Mattick et al., 2009). However, 
research and treatment recommendations regarding methadone treatment for individuals 
age 50 and older are lacking. Although the literature review conducted for the present 
study revealed that many researchers have studied methadone treatment as well as 
addiction and its impact on society and families, I found little about methadone use and 
older adults. Without this information, human service professionals cannot adequately 
meet the needs of older individuals on methadone.   
Purpose of the Study  
The purpose of the present study was to assess the relationship between 
methadone maintenance and the life experiences of opiate users ages 50–55 years. I 




Ten percent of people involved in some type of methadone treatment are age 50 years or 
older (Gossop & Moos, 2008). As methadone users age, treatment providers and others 
may need to review the physical and mental health and the continued illegal drug use 
among this population. Further, results from this present study can be used to help 
treatment providers determine the best modalities for helping opiate-dependent clients, 
particularly older opiate addicts who seek assistance in treating their addiction to opiates 
and other drugs. 
Research on methadone treatment and substance abuse among the identified 
population may help change the negative stigma associated with older addicts. 
Understanding the interconnectedness of older addicts’ needs is necessary for providing 
adequate care for this particular population. Researchers, legislators, and treatment 
providers may benefit by understanding the lived experiences of older opiate addicts.  
With the changes in methadone practices and policies over the years, research on this 
particular population may provide some clarity on the impacts these changes will have on 
continued methadone use.   
Significance of the Study 
There continues to be a significant gap in the treatment of addiction in the United 
States. As previously stated, 23,000,000 Americans acknowledge a need for treatment, 
but only 2,5000,000 addicts receive treatment (National Institute on Drug Abuse, 2011). 
Older adults in the United States consume over one third of all prescriptions drugs, which 
may place them at risk for developing a substance abuse problem (Gossop & Moos, 




in the aging population suggest that there will be a growing number of older people who 
may misuse or abuse drugs. Older opiate addicts, who began using early in their lives, are 
now aging and are changing the demographics of people needing substance abuse 
treatment (Rosen, Smith, & Reynolds, 2008). Reported drug use among older adults 
places greater demands on treatment programs (Ayres, Eveson, Ingram, & Telfer, 2012). 
Given the indications of increased drug use by older drug users, there needs to be a way 
to monitor the impact their drug use has on their lives and their communities. Research 
has shown that there is a major difference between people who receive therapy before age 
25 years and those who first come into treatment at a much older age (Chi et al., 2014). 
Methadone treatment programs are now working with older individuals who also 
present themselves with other significant problems such as complex health issues, 
transportation issues, and financial issues (Doukas, 2011). Methadone’s ability to 
decrease early deaths in opiate addicts has caused some people to stay on methadone for 
years (Doukas, 2011). Given the small amount of research specific to older methadone 
users, the present study’s focus was on examining their lives and understanding what it 
means to be an older addict dependent on methadone. I examined the lived experiences of 
older adults on methadone to help treatment providers meet the needs of this growing 
population.    
Little research exists regarding this population; therefore, this study is important 
to the addiction field as it increased the understanding of older opiate users and their 
specific variables such as family, medical and legal issues, and other relationships. Study 




among older adults. Study results can help inform substance abuse therapists and future 
areas of research. It was my hope to further the understanding of what is happening with 
this population and how society reacts to older people addicted to opiates.  
Problem Statement 
Studies have shown that heroin addicts who do not use methadone have a greater 
chance of relapsing or dying due to their drug use (Bell, Trinh, Butler, Randall, & Rubin, 
2009). With the exception of addicts who quit treatment in the beginning of their 
methadone therapy, those who stayed in treatment were able to maintain their sobriety 
longer than those who failed to use methadone (Bell, Trinh, et al., 2009). Although 
methadone has successfully been used as a major therapy tool for people addicted to 
different opiates, some questions remain regarding its long-term use (Ducharme, 
Knudsen, & Roman, 2006). Though relapse occurs for people addicted to alcohol and 
other drugs, opiate addicts are more likely to relapse than those addicted to other illegal 
drugs and alcohol (Marissen et al. 2006). In researching the literature regarding opiate 
use, I did not find much information regarding long-term methadone use in the older 
population.     
With the increase in dependency on prescription pain medications, as well as the 
increase on other pharmacological remedies for addiction, additional treatment methods 
are needed to address long-term recovery for opiate users, particularly older opiate users. 
Doukas (2011) noted that as methadone treatment has entered its sixth decade, programs 






The present study’s focus was on understanding the lives of older people addicted 
to opiates using methadone treatment to overcome their addiction. Two research 
questions were formulated to guide this inquiry. First, what are the lived experiences of 
opiate users ages 50–55 years who take methadone to manage their addiction? A follow-
up question was how do these same individuals remain consistent in their methadone 
treatment so that they can stay in recovery? Second, how do opiate user ages 50–55 years 
relate their particular experiences to the idea of recovery?  
Conceptual Framework 
The primary theoretical framework in this study was from Beck, Wright, Newman 
and Liese (1993), who developed a treatment modality for addicts using cognitive 
behavioral therapy (CBT). According to Pascoe (2008), the combination of behavioral 
and cognitive therapy created CBT. CBT is a psychotherapeutic approach that works to 
change clients’ behaviors by having them develop specific goals to meet their needs (A. 
C. Butler, Chapman, Forman, & Beck, 2006; Epstein, Hawkins, Covi, Umbricht, & 
Preston, 2003; Shah, Scogin, Presnell, Morthland, & Kaufman, 2013). CBT is not one 
specific approach to therapy but includes several approaches that share similar theoretical 
frameworks (MacLaren, 2008). These frameworks involve a variety of methods and 
therapeutic systems such as rational emotional behavioral therapy, cognitive therapy, and 
behavioral activation (Dobson & Dozois 2001).  
Therapists use CBT to treat a variety of problems including mood disorders, 




addiction treatment, therapists view substance dependency as a learned behavior acquired 
through experience (Pascoe, 2008). Therapists may use CBT in individual and group 
therapy as self-help applications for relearning or changing peoples’ thought patterns, 
emotions, and habits (Kadden, 2002).  
CBT’s framework is based on the idea that people’s problems result from their 
maladaptive or negative thinking that influences their emotions and behaviors (O’Donnell 
& Cook, 2006). Conducting a study on CBT combined with methadone treatment, 
Kouimtsidis, Reynolds, Coulton, and Drummond (2012) concluded that addicts who used 
methadone and CBT gained coping skills that helped them remain abstinent after 12 
months. Kouimtsidis et al noted that clients who underwent CBT increased their 
problem-solving skills and sought alternatives to their drug use. Kouimtsidis et al. 
showed results similar to a previous study on CBT in group therapy where addicts 
showed improvement regarding drug use, employment, and other aspects of their lives 
after 6 months (Scherbaum et al., 2005).  
CBT does not immediately eliminate drug use, but based on the Addiction 
Severity Index (ASI) this approach helps reduce their dependency over time (Epstein et 
al., 2003). One of the reasons for the improvement of dependency over time is that CBT 
focuses on present, not past behavior (O’Donnell & Cook, 2006). Using CBT for 
substance abuse clients involves identifying such issues as the severity of their addiction, 
the extent of their problems, their motivation for change, and the therapeutic relationship 
(McCrady, 2001). CBT further involves helping the client engage in self-monitoring and 




use. Working with addicts over time will help them identify and eliminate other triggers 
that lead to drug use and abuse. 
Therapists should encourage CBT clients to make changes based on their thoughts 
and belief systems. As clients’ belief systems help them achieve their goals, therapists 
should not dictate who the clients are or how they should be. CBT can help addicts cope 
with life more effectively by learning and relearning the way they think, feel and behave, 
which is consistent with how they want people to see them (Pascoe, 2008).  
Harm reduction has been one of the most influential ideas influencing drug 
treatment policies since the early 1980s (McKeganey, 2011). The idea of harm reduction 
began in the 1970s when Sobell and Sobell (1976) endorsed previous research that 
indicated some addicts were able to control their drinking after completing treatment. 
Methadone as a tool for harm reduction has been used in European countries since the 
late 1960s (Jarvinen, 2008). Early treatment in Europe was similar to that in the United 
States in which abstinence was the only goal for any drug regardless of what the addict 
wanted. The prevailing view in the United States has long been against any type of 
maintenance and has held methadone treatment as the addict continuing to engage in drug 
use (Drucker & Clear, 1999). Some drug courts have insisted that defendants on 
methadone reduce their usage or agree to become totally abstinent (Csete & Catania, 
2013). This position has given way to methadone treatment being stigmatized and 
misunderstood. Methadone treatment needs to become a standard psychopharmacological 




Nature of the Study 
The nature of this study was qualitative, which involved collecting data by 
interviewing methadone maintenance clients ages 50–55 years involved in a methadone 
clinic for at least 2 years, and who had been sober for at least 1 year. In addition, I 
conducted interviews with clients and gathered information regarding their history of use, 
relapses, length of time on methadone, any relapses while using methadone, and other 
treatment modalities they had used while taking methadone. Interviewing these clients 
provided information regarding how they perceive their lived experiences, addiction, and 
treatment experiences. The population I researched came from methadone programs in 
West Michigan. These programs have a large methadone population to choose from 
which allowed me to use a hermeneutic phenomenological approach in which 
participants described their experiences that I interpreted to understand their experiences 
on methadone and its significance in their lives. 
Definitions 
 Addiction Severity Index: The Addiction Severity Index (ASI) is a tool used in the 
field of addiction. Clinicians interview potential clients and gather information covering 
seven specific areas in their lives: legal, employment, relationship, alcohol, drug, 
psychiatric, and medical (Alterman et al., 1998; S. F. Butler et al., 1998). These seven 
areas serve as a rational inductive basis for the ASI items and their aggregation into 
scales (McLellan et al., 1992). The ASI can cover a person’s lifetime. However, the 
interviewer summarizes each of the fields using the composite scores for the addicts’ 




(Bovasso, Alterman, Cacciola, & Cook, 2001). The ASI is seen as reliable, valid, and 
consistent from intake to follow-up regardless of gender, age, race, or drug of choice.  
 American Society of Addiction Medicine: The American Society of Addiction 
Medicine (ASAM) is an organization for physicians with a focus on addiction and its 
treatment. The ASAM criteria are a broad set of strategies therapists use to place 
addiction clients in treatment and to discharge them (Kosanke, Magura, Staines, Foote, & 
Deluca, 2002). The ASAM criteria, also known as the ASAM patient placement criteria, 
are the most renowned professionally developed guidelines for ensuring addicts are 
placed in the correct level of care (Hays, 2006; Magura et al., 2003; Mee-Lee, 2013). The 
criteria allow therapists and others to evaluate and determine the severity of the client’s 
needs based on the six dimensions (Hays, 2006). The criteria are used for placing people 
with addiction in the level of treatment needed for recovery. In addition, therapists use 
the ASAM as a guideline for addicts continued stay or transfer to a lower level of care.   
 Antagonists: Opioid antagonists reduce the rate of relapse in clinical trials and 
reduce reinstatement in animal models of drug seeking (Perry & McNally, 2013). Using 
different antagonists helps limits overdosing and provides safety for the opiate users 
(Bickel & Amass, 1995). Antagonists also work for opiate-dependent clients. According 
to Carrol, Walsh, Bigelow, Preston, and Strain (2006), Tramadol has been used as an 
antagonist for opiate users. Tramadol has been marketed for approximately 50 years and 
has not shown to have abusive tendencies (Woody et al., 2003). 
 Co-occurring: Co-occurring refers to the treatment of both substance abuse and 




occurring as individuals who are diagnosed with a mental illness and substance abuse; 
however co-occurring is different from a dual diagnosis, which could indicate having 
more than one mental health disorder. Chandler, Peters, Fields, and Juliano-Bult (2004) 
used the terminology co-occurring disorders, co-morbidity, dual disorders, and dual 
diagnosis when a person was involved in the criminal justice and other systems (p. 433). 
Although there continues to be no universal agreement on how to treat clients with co-
occurring disorders, Minkoff and Cline (2006) argued that co-occurring disorder should 
be seen as the expectation not the exception.    
 Disease model: The disease model of addiction is supported in the United States.  
The disease model uses medical language to frame how people think of addiction in 
general (Shaffer, 1991). Thinking of addiction as a disease provides therapists a way of 
working with addicts by removing the notion of perspective treatment in addition to 
eliminating the therapists being too empathic to the problems (Margulies, 1989). Shaffer 
(1991) indicated that the disease model works with programs that encourage abstinence, 
but accept the idea that addicts will slip while in recovery. The disease model indicates 
that addicts have physiological differences from nonaddicts, and the reason for this could 
be genetic (Shaffer, 1991). Based on the disease model, addiction cannot be cured as 
addicts will be in a constant state of recovery. 
 Medication-assisted treatment (MAT): This approach has been available for 
treating alcohol and opiate use for some time. It is important in improving the health of 




providers have understood the use of MAT is as an important tool for treating addiction 
(Kelch, & Piazza, 2011).   
MAT’s function is to serve as a platform on which a recovery lifestyle can be 
built. Although MAT treatment reduces harm and physically stabilizes those who 
participate, it does not guarantee abstinence or guarantee being socially responsible 
(Rabinowitz, 2009). Although it continues to be a topic of debate in the United States, in 
other countries people using methadone are thought of as being in a MAT program 
(Laudet, 2007). MAT has been shown to improve opiate users’ lives by reducing the 
impact of addiction on their families and the community. Ginter (2012) noted MAT 
participants benefit from being involved in recovery groups and that it is important for 
recovery groups to support MAT’s use.    
Recovery groups: Recovery groups are self-help groups of people who 
acknowledge having similar problems and try to help each other work through their 
problems (Flora, Raftopoulos, & Pontikes, 2010). Self-help groups have grown 
significantly, particularly Alcoholics Anonymous (AA) and Narcotics Anonymous (NA).  
Using AA or NA as part of an addict’s aftercare treatment has demonstrated decreases in 
relapses and increases in abstinence from drugs or alcohol (Gossop, Stewart, & Marsden, 
2008). 
Addicts who are involved in recovery groups develop new relationships with 
people who are also abstaining from drug use and learn new coping skills to avoid 
relapse. One of the reasons people are involved in self-help groups is to identify with 




2013). B. S. Brown, O’Grady, Farrell, Flechner, and Nurco (2001) noted that older 
addicts attended NA meetings more often than younger addicts and have a more serious 
drug problem.   
Others have indicated that AA’s and NA’s approach is not for everyone. Ellis and 
Velten (1992) developed a self-help guide for people who wanted to stop drinking but did 
not believe in AA. They concluded that the main reason people used drugs and alcohol 
was due to their negative belief system in which they needed to develop strong goals and 
find a way to achieve these goals. Others have questioned recovery groups’ effectiveness. 
Peele, Bufe, and Brodsky (2000) argued the programs are not effective simply because 
they are popular. From their perspective, people do not benefit from being involved in 
AA or NA for a long period of time but rather from being motivated to make changes.   
Visual Analogue Scale: The Visual Analog Scale (VAS) is a measure used in 
research to determine pain intensity (Jensen, Chen, & Brugger, 2003). Researchers often 
use the VAS as it does not require as much explanation for participants compared to other 
measurements such as discrete scales (Reips & Funke, 2008). VAS is presented as a 
horizontal line fixed with two extreme descriptors (Flynn, van Schaik, & van Wersch, 
2004). Study participants who completed a survey using the VAS showed their 
agreement on the continuous line between those two points. The VAS is different from a 
Likert-type scale as the participants may respond to specific points on the scale. Savvas, 
Somogyi, and White (2011) used the VAS to measure opiate addicts’ emotional reaction 
to methadone use. Savvas et al. concluded that opiate addicts on methadone maintenance 




injection compared to nonaddicts who were in the study. This suggested that methadone 
reduces elative and depressive emotional reactivity (Savvas et al., 2011).   
Assumptions and Limitations 
 A major assumption in conducting a phenomenological study is that people will 
understand this methodology. Although some researchers have embraced 
phenomenological research for learning about people’s experiences, few are aware of the 
structure involved in this research methodology (Giorgi, 2006). Another assumption was 
that due to more multifaceted barriers, older methadone users may find it more difficult 
to follow methadone treatment expectations as compared to their younger counterparts.   
Three limitations were accepted regarding this study. First, phenomenological 
studies need only a small number of participants. Therefore, the results cannot be 
generalized to a larger population. Second, the success of any phenomenological study 
depends on the competency of the participants who share their stories, and what the 
researcher concludes (Valle & Mohs, 1998). A phenomenological study’s success also 
depends on whom the researcher chooses to be involved in the study and these 
individuals’ capacities for sharing the appropriate information. These limitations were 
applicable to the present study. The third limitation was that I may have had a bias as a 
nonaddict who is not in recovery. A variety of triangulation techniques were used in the 
present study to limit my perspective’s potential impact. Triangulation is further 




Summary and Organization of the Study 
The present study was intended to contribute to the literature regarding opiate 
dependency, with an emphasis on methadone use among older opiate users. The present 
study includes a definition of addiction, an examination of opiate user treatments, and a 
review of the information specifically addressing methadone users ages 50–55 years.   
Chapter 2 includes a comprehensive exploration of studies on methadone use, 
opiate dependency, addiction, and lives of methadone users. I also identified specific 
definitions and attempted to see them from the perspective of methadone users ages 50–
55 years. As such, each topic in this chapter was analyzed using a generalized and 
comprehensive evaluation that focused specifically on addiction, opiates, methadone, and 
relapse.   
Chapter 3’s focus is on the present study’s design, including participant 
enrollment procedures, informed consent procedures, and data collection methods. This 
chapter also includes a detailed description of the interview process and questions that 
were included in the interview as well as the analysis method. 
Chapter 4 includes information on how the data were generated and how 
participants were recruited. It also includes an account of the results and how participants 
answered the research questions and aided in initiating the origin of a theory related to 
opiate dependence and methadone use. 
Chapter 5 completes the present study with a discussion of results, implications 




and explanation of the findings reported in Chapter 4 as well as discussion of my 




Chapter 2: Literature Review 
Research since the early 1980s has shown the high rate of relapse and mortality 
for heroin users who are not involved in a methadone maintenance program (Bell, 
Shearer, et al., 2009). Today’s methadone clients are different from previous methadone 
users due to an increase in polydrug use (Doukas, 2011). There have been numerous 
longitudinal studies on heroin users; some have noted that 30% of heroin users continue 
to use in their old age (Hamilton & Grella, 2009).  
 The purpose of this literature review was to explore current research concerning 
addiction, heroin, methadone use, and opiate dependency, specifically looking at opiate 
users age 50 years and older. I gathered information on opiate addiction and also looked 
at different ways to prevent relapse. Addicts ages 50 years and older who were diagnosed 
with an opiate dependency were the focus. Few researchers have examined the lived 
experienced of this population and their methadone experience.      
Literature Search Strategy 
I obtained literature through an online search at Walden University as well as 
online research databases from Grand Valley State University and Western Michigan 
University. The primary instrument used was EBSCOhost, which included PsycINFO, 
PsycARTICLES, and SocINDEX. I used the following keywords to locate studies to 
review: opiate, relapse, methadone maintenance, gender, mortality, age, and addiction. I 
focused on journals specific to addiction such as Addiction, The American Journal of 
Drug and Alcohol Abuse, and Substance Use and Misuse. I also identified additional 




Introduction to the Literature Review 
Research has shown that many addicts continue their drug use despite the possible 
consequences of incarceration or death (Scherbaum & Specka, 2008). Society has often 
overlooked or failed to report drug abuse in the elderly (McGrath, Crome & Crome, 
2005). Widlitz and Marin (2002) called it the invisible epidemic due to the symptoms of 
abuse in older adults not being reported as compared to their younger counterparts. 
Although there is a wealth of information related to substance abuse, most researchers 
have focused on either prevention or treatment from a youth to middle-aged perspective. 
As a result, insufficient research regarding older adults and their addiction raises 
questions regarding public policies for addressing substance abuse in this population.  
Though society has considered addiction to illegal drugs a problem only young 
people experience, addiction has no age limit. With an aging population in the United 
States, more baby boomers who have acknowledged using or misusing drugs will need 
treatment (Briggs, Magnus, Lassiter, Patterson, & Smith, 2011; Gfroere, Penne, 
Pemberton, & Folsom, 2003). Entering their sixth decade for the treatment of opiate 
addiction, older clients are coming into methadone treatment programs not only seriously 
addicted to opiates but also with other major problems such as health issues (Anderson & 
Levy, 2003; Doukas, 2011; Firoz & Carlson, 2004; Kwiatkowski & Booth, 2003). It is 
important to determine how well these programs are meeting the needs of these clients 




Definition of Dependency and/or Abuse 
There are different definitions of addiction.  Some describe addiction as a disease 
state caused by the pharmacological outcomes of an incapacitating and ongoing drug use 
(Larance, Degenhardt, Lintzeris, Winstock, & Mattick, 2011; Naliboff, Wu, & Pham, 
2006; Sellman, 2010). Others define addiction as being compulsive and chronic with 
relapse being possible despite abstinence for several years (Miller & Gold, 2007; Van den 
Oever, Spijker, Smit, & De Vries, 2010; Witkiewitz, Lustyk, & Bowen, 2012). People 
who acknowledge having an addiction admit it becomes habit forming in that they 
constantly need the substance, engage in activities to secure their drug, and develop 
withdrawal when the drug is no longer available (Falcon & McClung, 2009; Witkewitz & 
Marlatt, 2004).   
Loss of control is another hallmark of addiction. Loss of control involves losing 
previous desires and acting impulsively and uncontrollably to obtain the drug 
(Prendergast, Podus, Finney, Greewell, & Roll, 2006). Addicts’ compulsive behavior 
may lead to other problems in their lives. Addicts may not realize how their behavior may 
become compulsive.  
Researchers have identified what they describe as the bottom-up and top-down 
processes involving the development and maintenance of compulsive behaviors (Koob & 
Le Moal, 2005; Redish, Jensen, & Johnson, 2008). Sellman (2010) noted that people who 
engage in addictive behaviors may have damaged the decision-making part of their brain, 
which contributes to the debate on whether or not addicts act compulsively. The debate 




primitive region of addicts’ brains puts their drug-seeking behavior into motion; 
therefore, they make decisions without thinking (Sellman, 2010). Vohs and Baumeister 
(2009) indicated that accepting the idea that people are responsible for their actions has 
some social implications for addicts. People who accept the idea that they are responsible 
for their actions are less likely to engage in behaviors society deems unacceptable.   
Researchers have found that opioid dependency is a chronic disease in which the 
addict may participate in the same negative behavioral pattern of using opiates despite the 
negative consequences (Elora-Orosa et al., 2010; Hellemans, Dickinson, & Everitt, 2006; 
van den Brink & Haasen, 2006). The Diagnostic and Statistical Manual (4th ed.; DSM–
IV) defines opiate dependency as “a maladaptive pattern of opioid use leading to clinical 
impairment or distress manifested within a 12-month period” (American Psychiatric 
Association, 1994, p. 248).  
Opiate dependency involves serious withdrawal symptoms that occur when opiate 
addicts are no longer consuming the drug (Hellemans et al., 2006; van den Brink & 
Haasen, 2006). To reduce their withdrawal symptoms, opiate addicts may return to their 
previous usage level and medicate themselves to reduce their stress level. Larance et al. 
(2011) noted that some researchers want to distinguish between the physiological 
dependency, which includes going through withdrawal, and the disorder itself. Larance et 
al. indicated that there are specific characteristics associated with dependency such as 
loss of control, craving, solely focusing on using the drug, and continued use knowing 
there could be consequences. Therapists need to identify these characteristics when 




argument as to whether addiction should be the primary diagnosis for people who use 
drugs or alcohol. Until there is a definition that supports the views of researchers and 
treatment providers, there will continue to be some debate regarding the definition and 
diagnosis. It remains unclear how the substance abuse profession will deal with 
diagnosing dependency.   
Definition of Opiates 
Opioids give addicts a euphoric feeling, and when that feeling is no longer there 
or they experience physical withdrawal symptoms addicts may return to their previous 
drug-seeking behavior and continue using the drugs (Bart, 2012; Ling, Mooney, & 
Hillhouse, 2011). Opiates commonly used are oxycodone and heroin. 
Oxycodone 
Oxycodone is a prescription opiate taken orally to relieve moderate to severe pain.  
Oxycodone is known to have a high potential for misuse and dependency (Middleton, 
Lofwall, Nuzzo, Siegal, & Walsh, 2012). People who misuse oxycodone may have severe 
withdrawal symptoms and may take more of the drug without their physician’s 
permission (Birnbaum et al., 2011; Miller & Gold, 2007). People who are addicted to 
oxycodone may snort the drug to achieve the feeling of euphoria (Middleton et al., 2012).   
Oxycodone withdrawal is similar to other opiate drugs. The symptoms, which are 
the same as other opiate-based painkillers, include anxiety, insomnia, muscle pain, panic 
attacks, and weakness (Beardsley et al., 2004). There is a risk of severe withdrawal 
symptoms if oxycodone is abruptly discontinued (“Oxycodone,” 2005). Gradual 




acknowledge using oxycodone to detox before these clients can begin residential or 
outpatient treatment.     
Heroin   
Heroin was designed to help addicts deal with their addiction to morphine (Gruber 
et al., 2006). Despite its negative effects, heroin use among adults has increased (Gruber 
et al., 2006). According to the National Survey on Drug Use and Health, older heroin 
users continue to use the drug despite their age (Rosen, Hunsaker, Albert, Cornelius, & 
Reynolds, 2011; SAMHSA, 2004). People who use heroin are more likely to become 
dependent on it within 2 years of taking the drug as opposed to people who use other 
drugs (Mowbray, Perron, Bohnert, Krentzman, & Vaughn, 2010). Roddy, Steinmiller, 
and Greenwald (2011) found that the majority of 109 heroin users interviewed engaged in 
similar behavioral patterns when it came to their drug use. These addicts admitted using 
the same amount of heroin daily, working with the same drug dealer, and participating in 
similar rituals during their usage (Roddy et al., 2011). These rituals included using the 
same amount of heroin in the same setting as well as where usage took place.   
 Heroin abuse is a serious worldwide health issue (Cousins et al., 2011; 
Degenhardt et al., 2011; Haile, Kosten, & Kosten, 2008; Nordit & Stohler, 2008). One 
reason for the abuse is that heroin addicts acknowledge that their addiction is chronic, 
which includes periods of relapses, increased tolerance, and unusual behaviors in order to 
continue their usage despite some negative consequences (Levran et al., 2009). A number 
of problems are associated with heroin use. High mortality levels and serious health 




can lead to increased risk of overdose, legal problems, and some health difficulties 
(Roddy et al., 2011). Others have indicated that heroin addicts crave the drug or become 
involved in illicit activities to secure the drug (Faarred, Vayalapalli, Casarella, Amar, & 
Drexler, 2010; Greenwald, 2002; Roddy et al., 2011).  Therefore, it appears that the 
continued use of heroin causes major problems in users’ lives. As one moves forward 
into examining how the United States engages in the treatment of heroin, it may be 
important to examine other countries’ policies for treating heroin addiction.    
Harm Reduction 
Harm reduction is the policies, programs, and practices that aid in reducing the 
negative impact of drug use on the addict (Jarvinen, 2008; McKeganey, 2012). Although 
total abstinence may be the goal for some programs, others see harm reduction as a 
reduction in drug use or using alternatives such as methadone to treat the addiction 
(Jarvinen, 2008). Although treatment focusing on being abstinent from drugs and alcohol 
use is effective, treatment providers and policymakers are seeing the importance of 
developing harm reduction interventions as both valuable and pragmatic (Phillips & 
Rosenberg, 2008).   
Although some people think harm reduction measures, like needle-exchange 
services and methadone treatment, increase illegal drugs, De Preux, Dubois-Arber, and 
Zobel (2004) indicated that harm reduction did not increase heroin use in Switzerland. 
Other countries have developed different strategies for working with people addicted to 
heroin. Nordt and Stohler (2006) noted that while other countries support harm reduction 




as policy leaders believe that the United States is fighting a drug war. Only recently in the 
latter part of the 20th century did some U.S. policymakers consider engaging in harm 
reduction for treating heroin addiction. Jarvinen (2008) examined inconsistent attitudes 
between treatment providers and addicts and found that harm reduction is providers’ 
primary treatment goal.   
Definition of Relapse 
Relapse is a challenge for addicts, particularly in chronic addiction in which 
people are likely to relapse even after being in treatment. Relapse is prevalent in people 
experiencing addiction (Sinha, 2011). Treatment providers have indicated that relapse is a 
symptom of the problem and can be continuous over the addict’s lifetime (Alemi, Haack, 
& Nemes, 2004). Society has often considered the term relapse to indicate a person’s 
failure in recovery (Sinha, 2010). However, in view of the previously mentioned studies 
relapse should not imply that addicts will remain sober for their life. The studies led to 
improving the understanding of how relapse is a challenge for addicts dealing with urges 
and cravings associated with stress, depression, and poor support system. In studies by R. 
M. Brown and Lawrence (2009) and Sinha (2011), more than two thirds of opiate addicts 
relapsed within a few months after completing treatment. Several factors can predict 
relapse risk, including stress, depression, craving, coping skills, and a person’s support 
system (Sinha, 2010; Witkiewitz & Marlatt, 2004). 
Regardless of the amount of time in and type of treatment, relapse is significant 
among opiate addicts. As such, it is important for people working in the field of addiction 




relapse prevention plan to overcome them. Understanding why treatment providers see 
methadone as the reliable treatment for opiate addiction will give therapists information 
to share with clients regarding their treatment choices.  
Drugs Used to Manage Opiate Addiction 
Methadone  
Methadone is a morphine-like drug for treating opiate addiction (King & Best, 
2011) that can stabilize opiate users. Methadone is a form of opiate replacement therapy 
designed to decrease heroin use and other health problems associated with opiate use 
(Dobler-Mikola et al., 2005). Physicians have prescribed methadone for heroin users in 
the United States since 1963 (Uchtenhagen, 2011). Methadone is considered one of the 
most valuable options in managing heroin and other opiate addiction (Kastelic, Dubajic, 
& Strbad, 2008).   
Methadone appears to be effective in treating most opiate addiction. Reviewing 
data over a 22-year period, Kornor and Waal (2005) noted that heroin addicts who started 
methadone treatment but stopped were more likely to relapse and return to the same level 
of usage. Methadone may help improve some opiate addicts’ lives. Banta-Green, 
Maynard, Koepsell, Wells, and Donovan (2009) completed a 12-month study on 
individuals addicted to opiates in the state of Washington. Examining the addicts’ 
retention in a methadone treatment program, Banta-Green et al. concluded that 
methadone treatment significantly improved the lives of people who were diagnosed with 




 Despite its proven effectiveness, not everyone who needs methadone can get it. 
Schwartz et al. (2008) noted that due to a lack of funding and equality regarding payment 
for treatment, some people are unable to secure methadone. Schwartz et al. further noted 
that some opiate users may be hesitant or have negative attitudes about quitting their drug 
use, which excluded them from a methadone program. As methadone has been the most 
recognizable treatment for opiate dependency, therapists should become familiar with its 
properties.  Termorshuizen et al. (2005) studied 732 participants in Amsterdam and found 
that opiate addicts who used methadone maintained their abstinence on a dose of 80 mg a 
day or higher. Kayman, Goldstein, Deren, and Rosenblum (2006) identified the 
importance of social conditions, program factors, and clients’ characteristics and attitudes 
in predicting how long an individual may stay in methadone treatment.   
Buprenorphine  
Approved in 2002, buprenorphine is an alternative to methadone for treating 
opiate dependency (Tetrault & Fiellin, 2012; Wish et al., 2012). Buprenorphine is often 
used as addicts are unlikely to abuse it yet has effectiveness similar to methadone (Tkacz, 
Severt, Cacciola, & Ruetsch, 2011). Combined with another opiate blocker such as 
suboxone, buprenorphine helps reduce opiate abuse (Proctor, Copeland, Kopak, 
Herschman, & Polukhina, 2014). Although methadone has been the main 
pharmacotherapy used in the United States for treating opiate dependency, buprenorphine 
treatment has increased (Gryczynski et al., 2013). Early studies on buprenorphine 
indicated that it was a safe alternative to methadone as heroin addicts on buprenorphine 




(2014) completed a 10-year study on opioid maintenance treatment. When comparing 
methadone and buprenorphine, Riksheim et al. found that buprenorphine use increased 
three times during the study period while treatment attrition decreased.  
Buprenorphine minimizes any abuse of the drug as well as the addict seeking 
other opiates while maintaining all positive qualities of methadone (Tkacz, Severt, 
Kassed, & Ruetsch, 2012). Although some addicts acknowledge abusing methadone, 
buprenorphine’s abuse levels are lower, and its treatment qualities are similar to 
methadone (Tkacz et al., 2011). Buprenorphine has helped reduce early stages of relapse 
and was demonstrated safe as compared to another opiate agonist (Wilford & Maxwell, 
2006). Buprenorphine is effective in treating opiate addicts, is accepted for treating 
addicts, and is another medication-assisted treatment for opiate addiction (Mendelson, 
Flower, Pletcher, & Galloway, 2008). 
Naloxone  
Naloxone is an artificial antagonist used for treating addition to various opiates, 
including heroin, morphine, or buprenorphine (Hill & McCauley, 2012). Naloxone is 
used to reduce mortality from opiate overdose (Strang et al., 2008) and was designed to 
reverse heroin’s effects by reducing respiratory depression, the primary cause of death in 
an overdose (Kerr, Dietz, & Kelly, 2008). Naloxone can be effective in treatment and can 
reduce methadone dose monitoring (Bell, Shearer, et al., 2009). 
Nondrug Treatment for Opiate Addiction 
Addiction treatment may range from detoxification to 12 step meetings.  Haile et 




and do not need treatment. However, people who do develop an addiction may require 
specific treatment. Detoxification is a form of treatment for addicts who are physically 
dependent on their drug and may need medical and mental health treatment to aid the 
recovery process (Sigmon et al., 2012). Some individuals may need a detox program 
before they can address their addiction. Miller and Gold’s (2007) study on opiate 
prescription medication showed that the perception of pain diminished if the person was 
involved in a detox program. Addicts and providers should not view detox as a 
standalone treatment as by doing so increases the chance of relapse (Tuten, Jones, Lertch, 
& Stitzer, 2007). Although some opiate addicts may need to detox before addressing their 
addiction, some may continue presenting with symptoms indicating that they may 
struggle without their pain medication. Nonetheless, more than 50% of individuals who 
start detox treatment fail to complete it (Marhe, Waters, van de Wetering, & Franken, 
2013). 
Providers have recognized and accepted the need for residential treatment for 
some addicts. Conner, Hampton, Hunter, and Urada (2011) reviewed treatment data from 
the California Alcohol Drug Data System from July 1, 2001 to June 30, 2006 and found 
higher treatment completion for individuals who were involved in residential treatment 
compared to traditional outpatient treatment.  Witbrodt et al. (2007) compared addicts 
who completed a residential treatment program to those who were only involved in 
outpatient treatment.  Study results showed that more than 50% of addicts involved in 
either treatment modality reported maintaining their abstinence from drugs 1 year after 




impact residential treatment has on maintaining an addict’s sobriety, no one has 
questioned the need for other treatment resources (Witbrodt et al., 2007). Opiate addicts 
may need additional resources for completing treatment.  Milligan et al. (2011) studied 
women’s treatment and found that helping women address their childcare needs and 
locate appropriate housing after completing treatment improved the women’s stay in 
treatment. 
Some individuals may need to go through treatment numerous times to address 
their addiction. The Department of Alcohol & Drug Services of Santa Clara County, 
California’s report on nearly 1,000 addicts involved in the criminal justice system 
indicated that 38% returned to treatment within 18 months of their initial treatment 
experience due to a lack of additional programming following their residential stay 
(Stanford, Banerjee, & Garner, 2010). In drug addiction treatment, as with other chronic 
conditions, addicts are likely to relapse without some type of monitoring. 
Although the percentage of people who acknowledge having an addiction to 
various opiates has increased, there has been a decrease in the number of addicts 
receiving treatment in programs that can address their specific needs (Conner et al., 
2011). People are not always placed in the best program for their addiction needs. 
Tetrault and Fiellin (2012) stated opiate addicts need to be in treatment programs that 
allow them to use different medications in order to remain sober. Despite the idea that 
some addicts will do better in treatment if they are allowed to take medications, 
Ducharme et al. (2006) stated that some treatment programs often discourage or prevent 




Thus, the debate continues on whether medication benefits individuals who are using 
other treatment modalities.    
Problems Associated With Opiate Use 
Many opiates, legal and illegal, can be misused. Morphine, oxycodone, and 
fentanyl are legal opiates for pain management (Byrne, Lander, & Ferris, 2009). Opium 
and heroin are illegal opiates (Wesson & Smith, 2010). Ling et al. (2011) identified 
several studies regarding drug abuse in the United States and concluded that prescription 
opiates misuse has increased to an epidemic status since 1990. People may be using 
methadone and buprenorphine medications for addiction treatment (Degenhardt et al., 
2011; Weiss et al., 2010). Older adults use as much as one third of all prescription 
medications, which include opiates and benzodiazepines (Gossip & Moos, 2008). Older 
adults may use more medication than their doctor prescribed or use medications 
belonging to someone else. In addition, older adults may swap or sell their prescription 
medications thus impacting their well-being and support network (Doukas, 2011). 
Pain Management 
People use prescription opiates for managing pain. Some pain management 
organizations support using opiate medications to help people manage their pain (Larance 
et al. 2011). Miller and Gold (2007) studied individuals using different opiates for pain 
management and noted that less than 1% became addicted to opiates. Pain management 
workers who treat older adults need education on how a person may become dependent 
on pain medications (Byrne et al., 2009). Therapists may need to develop different 




management and collaborate with medical professionals to provide the best possible 
treatment for these clients.  
Dangers of Opiate Drugs 
There are benefits and problems associated with using opiates. One benefit is that 
opiates help manage acute or chronic pain (Larance et al., 2011; Naliboff et al., 2006).  
One problem connected with the use of prescription opiates is that people may develop an 
addiction to the drug and need more of it. Another problem associated with opiate use is 
the impact on society such as violence inflicted on others, property damage, crimes 
related to acquiring and selling the drugs, and death (Cruts, Buster, Vicente, Deerenberg, 
& Van Laar, 2008; Grau et al., 2007; Panchanadeswaran, El-Bassel, Gilbert, Wu, & 
Chang, 2008). Heroin use may lead to overdose. One in 10 heroin users is likely to die 
because of an overdose (Degenhardt et al., 2011; Fatovich, Bartu, Davis, Atrie, & Daly 
2010).   
Drug use is connected to violent behaviors including intimate partner violence 
(IPV). Women involved in IPV may develop serious health problems (Chermack et al., 
2009; El-Bassel, Gilbert, Wu, & Hill, 2005; Stuart, O’Farrell, & Temple, 2009). Women  
who admit to being addicted to various drugs and also involved in an IPV relationship 
related to their drug use reported experiencing anxiety, depression, posttraumatic stress 
disorder, and an increase in alcohol and drug use compared to women not involved in an 
IPV relationship (Temple, Stuart, & O’Farrell, 2009). According to Panchanadeswaran et 
al. (2008) women who are addicted to various drugs and who are involved in an IPV 




more vulnerable to violence. Drug treatment programs and establishments that provide 
services to IPV victims need to collaborate on policies for assisting victims in recovery 
and life issues (El-Bassel et al., 2005). 
Women involved in substance abuse and who are victims of physical abuse need 
to work on reestablishing their social networks. Several studies have indicated that 
interpersonal relationships may have conflicting effects for women with addiction 
problems as these relationships may be supportive but also may be an impetus for relapse 
(Hamilton & Grella, 2009; Walitzer & Dearing, 2006). Stuart et al. (2009) noted the 
importance of identifying and treating the violence and addiction in the relationship early 
on. Stuart et al. found that abusive partners reported a significant decrease in their violent 
behavior a year following their treatment. IPV, psychiatric issues, and high-risk sexual 
behaviors are just the tip of the iceberg regarding issues among opiate users.  
Previous research has suggested a correlation between addiction and violent 
behavior against another person (Lipsky, Caetano, Field, & Larkin, 2006). When 
considering both demographic and substance use factors, Lipsky et al. concluded that 
people connected to drugs are more likely to use emergency rooms and shelters due to 
some type of violent behavior. Older addicts are subject to violence as well. Older addicts 
have indicated being the victims of violence and power struggles with drug dealers due to 
their age (Anderson & Levy, 2003). Older users noted that having a different background 
or social status than their dealers may have caused some of the personal conflicts 




Illegal Drug Use 
Illegal drug use among older individuals is major concern. Like younger addicts, 
older addicts use illegal drugs (Colliver, Compton, Gfroerer, & Condon, 2006; Hamilton 
& Grella, 2009; Rosen, 2004; Rosen et al., 2008; Simoni-Wastila & Yang, 2006).  
Studying the connection regarding life stressors and exposure to illegal drug use, Rosen 
(2004) researched 143 adults over age 50 years and found that their exposure to illegal 
drugs greatly increased their involvement with the substance.  
Much attention has been paid to the harmful effects of prescription medications.  
Cleland, Rosenblum, Fong, and Maxwell (2011) noted that during a 10-year period, 
treatment programs reported a 4% increase in prescription opiates being people’s primary 
drug of choice. As opiate addicts aged, they have gone from using heroin as their primary 
drug to other opiates in order to meet their drug needs (Anderson & Levy, 2003). This 
behavior may suggest that even though society does not accept the idea that older drug 
addicts use illegal drugs compared to their younger counterparts, older drug users will 
find a way to secure their drug needs.   
Similar to younger people, older adults may abuse legal and illegal drugs. Older 
adults may become addicted to psychoactive medications (Gfroerer et al., 2003). Like 
younger addicts, older addicts obtain psychoactive medications without having a written 
prescription (Crome, Sidhu, & Crome, 2009). Older adults may also share highly 
addictive medications or take higher doses for longer periods than were originally 
prescribed (Anstice, Strike, & Brands, 2009; Simoni-Wastila & Yang, 2006). Older 




(Simoni-Wastila & Young, 2006). Continued exposure to illegal drugs in the older 
addicts’ social network and community will likely increase the chances of their 
continuing such behavior.  
Addiction and HIV   
The incidence of alcohol or other drug addiction among HIV-infected individuals 
is significantly higher than that of the U.S. population that does not have HIV (Benard et 
al., 2007). Users of injected drugs are at high risk of contracting HIV through reusing and 
sharing syringes and other injection paraphernalia. In 2006, 24% of persons living with 
HIV had been infected through injecting drugs (Meade, McDonald, & Weiss, 2009). 
Approximately two thirds of heroin users inject the drug and thus are at high risk for HIV 
infection. Compared to nondrug users, female drug users are at a greater risk of HIV due 
to their increased sexual behaviors (Cohen et al., 2009; El-Bassel et al., 2005; Kelly et al., 
2009). Burns, Conroy, and Mattick (2010) noted that women who have a substance abuse 
problem are more likely to be exposed to health problems due to injecting drugs and 
engaging in unprotected sex in exchange for drugs. Significant comorbidity exists 
between HIV infection and substance use disorders as they are linked (Byrd, Murray, 
Safdieh, & Morgello, 2012). Opiates abuse is a major transmission route while abuse of 
other illicit substances, such as cocaine and methamphetamine, has become a primary 
risk factor for HIV infection (Centers for Disease Control, 2007). 
Sexual Behaviors in Addiction              
 There is a link between drug use and sexual risk behaviors. Several researchers 




behaviors (King, Nguyen, Kosterman, Bailey, & Hawkins, 2012; Kopetz, Reynolds, Hart, 
Kruglanski, & Lejuez, 2010). Hayaki, Anderson, and Stein (2006) found that heroin users 
engaged in risky sexual activities such as acting without thinking. Cohen et al. (2009) 
indicated that a disproportionate number of women involved in substance abuse treatment 
acknowledged childhood sexual abuse that contributed to their drug usage. Women are 
more susceptible to the negative consequences of drug use and high-risk sexual 
behaviors. Programs designed to treat women with drug problems, particularly those who 
may be a victim of childhood sexual abuse, may provide a special opportunity to focus on 
and treat both issues. Treating both is relevant and beneficial for reducing drug 
dependency and improving the lives of these women and their families. 
Mortality From Addiction 
Mortality is an issue for opiate users. The mortality rate for opioid-dependent 
users is 30 times higher than the general population (Clausen, Waal, Thoresen, & 
Gossop, 2009). The reasons for their deaths include taking more of the drug than 
intended, being the victim of a homicide, committing suicide, or failing to secure 
appropriate medical care (Clausen et al., 2008; Clausen et al., 2009).  Woody, Kane, 
Lewis, and Thompson (2007) found fewer deaths for users who stayed on their 
methadone regime. These findings, along with those from previous studies, demonstrate 
that staying on methadone reduces mortality as the addict is less likely to return to his or 
her using behavior. Figure 2 illustrates the number of deaths contributed to heroin and 





Figure 2. Rates of death associated with heroin and prescription opioids, 2003–2013. 
Adapted from “Trends in Opioid Analgesic Abuse and Mortality in the United States” by 
R. C. Dart, H. L. Surratt, T. J. Cicero, M. W. Parrino, S. G. Severtson, B. Bucher-
Bartelson, & J. L. Green, 2015, The New England Journal of Medicine, 372, p. 241. 
Copyright 2015 by The New England Journal of Medicine.   
 
Mortality affects older addicts as they are at least 6 times more likely to die from 
their addiction or from other issues when compared to younger addicts (Crome et al., 
2009). Older addicts are likely to die from an overdose or suicide although medical issues 
such as cancer and heart problems may also contribute to their death (Hser et al., 2004; 
Kwiatkowski & Booth, 2003). Although older people are nearing the end of their life 
cycle, Doukas (2011) found limited research focusing on mortality and the reasons for 




unhealthy behaviors that could increase the probability of death such as smoking, failing 
to exercise, and overeating (Fareed et al., 2009).   
Psychiatric Problems in Addiction 
Some addicts with an identified psychiatric problem may also self-medicate 
themselves with drugs and alcohol. The reason for using drugs and alcohol is to relieve 
distresses that may or may not be connected to specific psychiatric problem (Gil-Rivas, 
Prause, & Grella, 2009). Because of the stigma of mental health diagnosis, some people 
may use opiates rather than address their psychiatric problem (Green, Grimes Serrano, 
Licari, Budman, & Butler, 2009; Zacny, Gutierrez, Kirulus, & McCracken, 2011). Using 
information gathered from the National Epidemiological Survey on Alcohol and Related 
Conditions, Martins, Keyes, Storr, Zhu, and Chilcoat (2009) found that people who were 
already diagnosed with generalized anxiety disorder were at an increased risk of taking 
nonprescription opiates and had a higher risk of developing an opiate dependency.   
Therapists need to understand the impact mental health issues have on people 
with addiction. Maremmani et al. (2010) identified several studies on the differences 
between men and women with psychiatric disorders. Maremmani et al.’s research 
indicated that women are more likely to be diagnosed with depression and anxiety while 
men are more likely to be diagnosed with schizophrenia and antisocial behaviors. Further, 
researchers have found that women who abuse drugs are more likely to be diagnosed with 
psychiatric problems than men (Eiroa-Orosa et al., 2010; Green et al., 2009).   
Older opiate addicts are likely to identify with having some type of mental health 




interviewees acknowledged having at least one mental health disorder. Depression or 
generalized anxiety disorder were the primary diagnoses. Rosen’s results appear to be 
similar to those of Firoz and Carlson (2004), who found that at least 25% of older 
methadone users admitted to having a psychiatric disorder. Comparing older opiate users 
to younger ones, both groups acknowledged mental health problems but older users 
denied experiencing posttraumatic stress disorder (Wu & Blazer, 2011). Regardless of 
any physical conditions, older addicts are less likely to seek treatment for mental health 
issues than their younger counterparts as older addicts see depression and other mental 
health disorders as part of the aging process. (Braden et al., 2008).   
Medical Problems Associated With Opiate Addiction 
Prescription opiates are a problem that treatment providers cannot ignore. Weiss 
et al. (2010) indicated that most opiate treatment focused on heroin addiction even though 
people had increased the prescription opioid use. Weiss et al. further noted that with 
increased opiate prescription use, it is important to understand how these individuals may 
engage in treatment. Using different sites for opioid addiction treatment, Weiss et al. 
viewed how people addicted to different opiate responded to outpatient treatment of 
buprenorphine along with therapy. Weiss et al. stated that most people who take 
prescription opioids for treating specific chronic pain do not see themselves as addicts 
and want to classify themselves in a different subpopulation.    
Older opiate users may have some medical issues that their addiction impacts.  
Rosenblum et al. (2007) interviewed 140 methadone clients age 50 years and older.  




hypertension (Rosenblum et al., 2007, pp. 495–496). Data from methadone treatment 
programs have indicated that older clients present with pulmonary problems and liver and 
kidney diseases as well as other serious infections affecting the quality of their lives 
(Rosen et al., 2008). Comparing two different opiate maintenance client groups, Lofwall, 
Brooner, Bigelow, Kindbom, and Strain (2005) found that older opiate users had more 
medical problems and poorer overall health than younger opiate users. Studying more 
than 90 clients age 40 years and older involved in methadone, Fareed at al. (2009) found 
that more than 70% had hypertension as well as coronary artery issues. Fareed at al. 
concluded that continued methadone use correlated with serious medical problems that 
put these clients at risk for premature death.     
Criminal Behavior Associated With Opiate Addiction 
Addiction may increase the possibility of criminal justice system involvement. 
Many heroin addicts are incarcerated because of their drug habit and criminal behavior 
(McMillan, Lapham, & Lackey, 2008). Of the 2,000,000 people who were incarcerated in 
the United States in 2002, 12%–15% admitted to being addicted to heroin and/or other 
opiates (M. S. Gordon, Kinlock, Schwartz, & O’Grady, 2008). Studying research from 
several countries, Oliver et al. (2010) found that most opiate addicts supported their drug 
use by engaging in illegal activities such as dealing drugs. Even though addicts in the 
United States may be incarcerated 4 times as often as compared to other industrialized 
countries, their decisions to continue using heroin and other opiates following their 
incarceration remains a major problem (A. J. Gordon et al., 2011). Incarceration can be 




may receive treatment while incarcerated or when released (Taxman, Cropsey, Young, & 
Wexler 2007). Research supports methadone as highly effective in reducing an inmate’s 
addiction to heroin or in reducing criminal behavior (A. J. Gordon et al., 2011; Lobmann 
& Verthein, 2009; Oliver et al., 2010; Werb et al., 2008). 
Cravings for Opiate Drugs 
Opiate addicts experience cravings, which are a physical state that may cause 
addicts to seek their drug of choice despite the negative consequences (R. M. Brown & 
Lawrence, 2009). Cravings can be part of a withdrawal during which the addict may 
identify problems such as lack of sleep, mental health issues, and other discomforts 
lasting for an extended period of time (Fareed, Vayalapalli, et al., 2010). Heroin addicts 
admit that they often crave for a greater amount of the drug (Fareed, Vayalapalli, et al., 
2010; Wang et al., 2011; Weiss et al., 2010). Clinical studies on heroin addicts have 
shown that opiate addicts who use methadone report a decrease in their cravings for 
heroin (Fareed, Casarella, Amar, Vayalapalli, & Drexler, 2010; Wang et al., 2011). Wang 
at al. (2011) studied 14 former heroin addicts who were medication complaint in long-
term methadone maintenance programs. Using an event-oriented functional magnetic 
resonance imaging task involving heroin- and non-heroin-related cues, Wang et al. found 
that although there were no significant craving changes connected to the task, opiate 
addicts’ blood oxygen levels significantly increased when shown heroin-related cues. 
Study results showed that even though people may be sober from their drug for a 




and that opiate addicts reported having strong cravings and could relapse when exposed 
to heroin cues. 
There are medications that may help reduce the cravings for heroin. Fareed, 
Vayalapalli, et al. (2010) noted results from seven studies showing that methadone could 
reduce heroin cravings. Studying brain activity, Fareed, Vayalapalli, et al. found that 
heroin craving is connected to different neural circuits in the brain. Using the 10-point 
VAS scale, Fareed, Vayalapalli’s study indicated that rapamycin reduced heroin cravings. 
In a study on dopamine transporters, Shia et al. (2008) found a reduction in heroin 
craving and anxiety in opiate addicts taking methadone maintenance. Barta, Kurth, Stien, 
Tennen, and Kiene’s (2009) study of heroin craving, indicated some inconsistency on 
whether or not methadone would decrease cravings in opiate addicts. If addicts using 
methadone experienced high self-efficacy they were more likely to have low heroin 
cravings (Barta et al., 2009). These studies suggest that methadone could decrease or 
have no effect on cravings.   
Methadone dosage appears to impact heroin cravings. Greenwald (2002) 
suggested that heroin cravings increased when methadone dosage decreased. Results 
from later studies supported Greenwald’s findings in noting that addicts had better 
craving control when receiving 100 mg of methadone or more daily (Donny, Brasser, 
Bigelow, Stitzer, & Walsh, 2005; Fareed et al., 2009). It is important to be careful when 
interpreting data from these studies: One issue noted in the majority of these studies is 
that cravings may be impacted by other illicit drug use rather than changes in methadone 




being in a methadone program. Even though methadone is recognized as a safe substitute 
for their heroin use, some participants in Fareed et al.’s 2009 study admitted that their 
cravings could be a relapse trigger.   
Barriers to Treatment for Opiate Addiction 
There are some significant barriers to receiving treatment. Many heroin users rely 
on public funding to pay for their treatment, which could be a major barrier due to the 
limited number of treatment beds available in many communities (Mowbray et al., 2010). 
Research on how addicts engage in their drug use and current barriers to treatment is 
needed to develop strategies for organizing treatment programs and developing 
appropriate interventions for all opiate users.   
Several barriers may affect treatment for substance abuse in older individuals. 
One is the stigma associated with drug use. Stigma is seen as one of the most extensive 
barriers preventing older addicts from seeking treatment (Conner & Rosen, 2008). 
Completing a qualitative study at a methadone clinic, Conner and Rosen (2008) found 
that older adults identified how society views people with addiction as a negative stigma. 
Older female addicts indicated that some family members had discouraged them from 
being in treatment as the family members may struggle with the stigma of having a close 
relative with a drug problem (Conner & Rosen, 2008; Koenig & Crisp, 2008).  
Having a drug problem is one of the most significant stigma older addicts 
identify. Older addicts admit feeling angry and embarrassed by society stigmatizing them 
as drug addicts (Ayres et al., 2012). This feeling of shame and embarrassment often 




Koenig and Crisp (2008) noted that these barriers can impact service delivery and 
treatment for older addicts. As older individuals age and are identified with an addiction 
problem, treatment program providers need to understand how stigma impacts older 
opiate addicts and develop treatment strategies that are sensitive and ready to address 
these stigmas.  
Policymakers may need to revisit existing policies to see if these policies meet the 
needs of older addicts. Service providers who accept Medicare are limited in the number 
of treatment contacts with Medicare recipients, which makes it difficult to treat clients 
consistently (Kaskie, Imhof, & Wyatt, 2008). One problem associated with aging 
individuals who present with mental and substance abuse problems is that services do not 
correspond very well with the need for their care as less than 25% of older adults needing 
treatment will receive individual therapy (Kaskie et al., 2008). Completing a report on the 
aging, the Administration on Aging called for the improved integration of services 
between the aged person’s primary care physician and his or her treatment provider 
(Hinrichsen, 2010).   
Older Addicts  
Substance abuse affects people regardless of their age. There is some discrepancy 
in how older adults are defined. Researchers in the United States have defined an older 
adult as anyone 50 years of age and older (Gfroerer et al, 2003; Simoni-Wastila & Yang 
(2006). Other countries such as Great Britain have defined an older adult as anyone 40 
years of age and older (Crome et al., 2009). As the U.S. population ages, there will be a 




Gossop & Moos, 2008). It is estimated that the number of individuals 50 years of age and 
older needing addiction treatment may increase as much as 300% by the year 2020 
(Crome et al., 2009; Gossop & Moos; Gfroerer et al.; Rosen, 2004; Simoni-Wastila & 
Yang, 2006).   
Despite the increased amount of information regarding the epidemiology and/or 
treatment for addiction among older adults, there was not research on this subject until 
the early part of the 21st century (Kwiatkowski & Booth, 2003). There has been limited 
research regarding methadone treatment for opiate addiction in older adults. Doukas 
(2011) stated that while methadone maintenance treatment programs have existed for 
over 60 years, these facilities are now treating patients who are older and may be 
presenting for treatment for the first time in their 50s, 60s, and even their 70s. 
Rajaratnam, Sivesind, Todman, Roane, and Seewald’s (2009) study of methadone clients 
indicated that older methadone users presented with greater medical needs as well as a 
greater need for medications. Unlike their younger counterparts, older drug users are 
more likely to use medical treatment and follow up with medical care. With the increase 
in older drug users, there needs to be improved communication with health care 
professionals. As older addicts are emerging, program providers who serve older people, 
particularly drug programs, will need to identify this population’s unique needs (Rosen et 
al., 2008). Increased substance use among the baby boomer population will place greater 
demands on treatment programs not equipped to address this population’s needs (Lofwall 




Levy and Anderson (2005) labeled older drug users as having a drug career due 
to their long history of drug use. The idea of having a drug career has been used to 
explain how addicts begin using their drug of choice and continue as they become 
chronic drug users (Kwiatkowski & Booth, 2003). With addicts’ continued use as they 
age, addicts are no longer the primary persons involved in the drug culture, and their 
involvement in the drug world may be unknown to others unless they become the victims 
(Anderson & Levy, 2003). As the drug world older addicts first became involved 
disappears, older addicts may lose their social status as and try to hold on to past self-
identity and cultural values.    
Summary 
Opiate addiction is a complicated issue. People who continue their opiate use 
despite such consequences as death and incarceration recognize that many factors can 
possibly affect their usage. Feelings of powerlessness and unmanageability are so great 
that people addicted to opiates understand that their lives have become unstable.  
There is limited information supporting any significant gender differences for 
older opiate addicts. There are considerable similarities related to the interactive effects 
of substance use and aging and social relationships. Such gender problems may continue 
and even intensify as these addicts age. As women age, they may face different barriers 
and facilitators to gaining access to treatment as opposed to younger women. Younger 
women often see their parental roles impeding their decision to seek treatment while 
older women identify issues such as mobility and age-related health problems affecting 




with the health care system, additional research is needed on possible gender differences 
in the course of their addiction and treatment. Even though substance misuse is increasing 
and is becoming a significant problem for older adults, there is little information about 
older adults who may misuse substances. Professionals who work with this population 
may lack practical skills needed for addressing some difficult ethical issues that may 
come about in the context of working with older opiate addicts.   
Further discussion regarding the techniques used to gather information for the 
literature review as well as the techniques used to gather information regarding 
methadone usage, relapse issues, and live experiences is in Chapter 3. Chapter 3 includes 
a discussion of ethical considerations, study methodology, the sampling method, and the 




Chapter 3: Research Method 
Understanding a phenomenon requires in-depth knowledge of the perspectives of 
those who have lived through the experience. Qualitative research serves as a conduit for 
this process in an organized and systematic fashion (Marshall & Rossman, 2006). Tesch 
(1990) stated that individuals assign meaning to their objective world and that their 
valued experiences are situated in a historical and social context. Tesch further stated that 
there can be multiple realities for these experiences.   
My intent for the present study was to use a heuristic phenomenological approach 
to explore the lived experiences of opiate users ages 50–55 years currently on methadone.  
I examined their lives, their addiction history, and how using methadone has influenced 
their lives. Treatment providers may need to review this population’s physical and mental 
health as well as continued drug use. I gathered data related to participants’ history of 
use, any relapses, and length of time on methadone. I also wanted to know about any 
relapses as well as other treatment modalities participants used while taking methadone. 
Interviewing these individuals provided information regarding how they perceived their 
lived experiences, addiction, and treatment experiences.   
Examining Lived Experiences 
 Van Manen (1990) stated that when studying a phenomenon, a qualitative method 
is the most relevant tool to use as the study will be exploratory in nature. The goal of 
qualitative research is to provide information to gain a better understanding of an 
occurrence (Braud & Anderson, 1998; Creswell, 2007; Denzin & Lincoln, 1998; 




thorough investigation of the lived experiences of older methadone users. Patton (2002) 
described a lived experience as researchers having direct involvement with the 
phenomenon of interest instead of gaining the information from secondhand sources.  
Denzin and Lincoln (1998) indicated that a qualitative method is the best scheme for 
studying human experiences in order to gather the phenomenon’s complexity. 
Phenomenology 
Phenomenology is the study of lived experiences or the life world (van Manen, 
1990). Husserl designed the phenomenological research method in the early part of the 
20th century as a response to the traditional scientific method (Giorgi & Giorgi, 2001; 
Laverty, 2003; Lin, Huang, Chen, & Shao, 2009). Husserl argued that the traditional 
scientific method could not adequately or appropriately capture a phenomenon’s 
abstractions due to its focus on measuring observable concrete events (Powers & Knapp, 
1995). Phenomenology is the chosen methodology when wanting to understand the 
essence of an experience (Creswell, 2007). Phenomenological research invites the 
researcher to observe the participants’ world and learn different human behaviors (Valle 
& Mohs, 1998).   
In review, the focus of a phenomenological study is on exploring the relationship 
between people and their lived experiences, taking into consideration their customs, 
community, and historical environments. Combined, these factors may impact the ways 
in which people observe, identify with, and make sense of their daily experiences 




users coincides with an informative concept for examining participants’ lived experiences 
on methadone.    
Taking a phenomenological approach allowed me to explore participants’ lived 
experiences from a first-person point of view (Smith, Flowers, & Larkin, 2009; van 
Manen, 1990). Basically, phenomenology allowed me to examine participants’ life 
worlds as they were deliberately and purposely reflected upon (Husserl, 1998). Taking a 
phenomenological approach allowed me to explore the significance, for some people, of 
their lived experiences in relationship to a particular phenomenon (Polkinghorne, 1989). 
The present study focused on the lived experiences of opiate users ages 50–55 years 
currently on methadone. I examined their lives, their history of addiction, and how 
methadone use has influenced their lives.   
Braud and Anderson (1998) indicated that phenomenology is used to create a 
clear explanation and awareness of a specific human experience. To acquire a good 
understanding of the lived experiences using the phenomenological approach, researchers 
need to study fewer participants but do so more meticulously (Creswell, 2009; 
Moustakas, 1994). In the present study two different heuristic techniques were used to 
study older methadone users.  
The Heuristic Approach 
 Heuristic research characterizes the phenomenological emphasis on meaning 
through personal experiences. The two methodological techniques used for heuristic 
inquiry in the present study were engaging in a face-to-face conversation with the 




having the participants’ experiences as the focal point throughout the research 
(Moustakas, 1990; Patton, 2002). For the present study, I engaged in conservation as part 
of the heuristic approach.  I spoke, listened, reflected, and talked again to the participants 
to gain a clearer understanding of the phenomenon. Moustakas (1990) suggested that this 
method involves cooperating and sharing to open a pathway for explicating the 
phenomenon being investigated.   
 There are four approaches to phenomenology research: traditional, experimental, 
hermeneutical, and empirical or transcendental (Klein & Westcott, 1994). For the present 
study, the hermeneutical approach to phenomenology using the work developed by van 
Manen (1990) was chosen as a suitable methodology. Hermeneutic phenomenology has 
become a more popular research method as it is used to examine life world or human 
experiences as the study has a focus on revealing the specific and seemingly trivial 
aspects in the experience that others may take for granted (Laverty, 2003; Wilson & 
Hutchinson, 1991). Hermeneutic phenomenology also involves a presupposition that the 
essence of an experience is interpretable, and therefore knowable. 
Hermeneutic phenomenology is attentive to the philosophical foundation of 
hermeneutics and phenomenology (van Manen, 1990). Ajjawi and Higgs (2007) noted 
that to be successful, research strategies need to flow directly from the project’s research 
question and goals. This methodology aligned with my goal of attempting to understand 
the lived experience of methadone users ages 50–55 years. In essence, phenomenology 
best fit my desire to explore the lives of older methadone addicts. Few studies have been 




consistent with the philosophy of phenomenology to give richness, depth, and insight into 
the phenomenon under investigation.   
Research Questions 
I focused on understanding the lives of individuals who were addicted to opiates 
who were using methadone as a tool for relapse prevention. I also looked at other 
treatment modalities participants were using or had used to remain sober. I formulated 
two questions to gain this understanding. The first question was what are the lived 
experiences of opiate users ages 50–55 years who take methadone to manage their 
addiction? A subquestion was how do opiate users ages 50–55 years on methadone 
remain consistent in their methadone treatment so that they can stay in recovery? The 
second question was how do opiate users ages 50–55 years relate their particular 
experiences to the idea of recovery? Although the literature review showed that many 
researchers have studied methadone treatment as well as addiction and its impact on 
society and families, there remain gaps in the research when it comes to methadone use 
and older adults. It is possible that continued dependency on a substance, despite it being 
legal, is construed differently than maintaining total abstinence from any substance.  
Informed Consent Process 
To gain access to participants, I obtained the approval from Walden University’s 
IRB (Walden University’s approval number for this study: 09-18-15-0133502) to make 
sure the interview questions posed no harm to the participants and were asked in such a 
way that information flows  smoothly and willingly during the interview process 




and data collection steps to make sure they were within the ethical guidelines established 
by Walden University. Once I received permission, I sent fliers to various places that 
addicts are known to frequent. To maintain an ethical study, individuals who agreed to 
participate signed a consent form prior to study participation. Participants were invited to 
contact me prior to signing the consent form with any questions or concerns they may 
have, and I responded appropriately and promptly. Participants could withdraw from the 
study at any time without prejudice.  
Participants 
I sought male and female participants who had been on methadone for at least 2 
years, who were involved in a methadone clinic, who were not currently involved in a 
residential treatment program, and who resided in one of three metropolitan areas in the 
state of Michigan. I identified individuals from a purposive sample based on their ability 
to comprehend the research problem and the primary phenomenon being examined in the 
study (Creswell, 2007). According to Dukes (1984), eight to 10 participants are an 
adequate sample size for a phenomenological study. For the present study, I interviewed 
participants until I reached a saturation of methadone users who were 50–55 years of age.   
One of the reasons for choosing this particular population is that previous research has 
shown that inequalities in being admitted to appropriate treatment programs for substance 
use correlate with a greater risk of substance-related death for older adults using 





 I used a purposive sampling to recruit prospective participants. Purposive 
sampling was appropriate as I sought an in-depth understanding of lived experiences 
from the participant’s standpoint (Babbie, 2010). Sample sizes for these types of studies 
are typically small (i.e., five and 10 participants) to allow for an in-depth, incisive 
examination of a phenomenon of interest. Also, purposive sampling is preferred when the 
goal is to draw from hidden or marginal populations that are difficult to access (Creswell, 
2007). Unlike quantitative studies in which the goal is to generalize to larger populations, 
phenomenological research’s aim is to acquire a deep, contextual understanding of lived 
experiences (Denzin & Lincoln, 2011).   
According to Creswell (2007), purposive sampling refers to selecting people and 
the place for the study because both can purposefully inform an understanding of what 
the researcher is attempting to learn. Using a purposive sampling allowed me to study a 
small subsection of a larger population (Babbie, 2010). It was my hope that by including 
only participants who meet the predetermined criteria, these individuals would be 
credible informants about the phenomenon under investigation. I chose participants who 
met the following criteria: male or female, 50 -55 years old, diagnosed with opiate 
dependency, involved in a methadone maintenance treatment program for at least 2 years, 
and no relapse reported in the previouss year. This information was gathered from the 
background questionnaire that potential participants completed after providing their 





To recruit participants for the study, I send out fliers to specific places near 
methadone clinics in three counties in the state of Michigan to identify potential 
participants. I sent fliers to places such as soup kitchens, recreational facilities, homeless 
shelters, and churches near the clinics. I also placed fliers in NA/AA meeting places in 
the three counties. I contacted therapists who work with people with addictions and asked 
them to place fliers in their waiting rooms for possible participants to view and consider.  
One agency placed a copy of the flier on its Facebook page, and I put a copy on my 
LinkedIn page. Appendix A is a sample of the recruiting flier. 
I used insiders to gain access to potential participants. Creswell (2007) identified 
insiders as individuals used to gain access to a group or cultural site. Insiders for the 
present study were leaders of NA/AA groups and therapists. Because of the close-knit 
culture of addiction and possible mistrust of researchers, insiders were vital to the present 
study as they helped ease any preexisting tension between the field of social science and 
the addiction community. This relationship gave me access I may not have been able to 
gain on my own. These insiders were individuals with whom I have trusted relationships 
and who either were working with the subjects in their clinics or had access to the 
subjects via contracts. To ensure no perceived coercion, the insiders’ role was to 
advertise in their clinic or meeting place for possible study subjects. The insiders did not 
know who participated in the study and who did not. The selection process continued 
with selection based on criterion sampling until the N of eight was reached. Once I had 




Of all of the recruiting modalities, placing fliers in treatment programs provided 
the most responses for potential participants. In response to the fliers, I received 12 phone 
calls from people in the greater Grand Rapids, Michigan, area who indicated they were 
interested in being in the study. I kept a log of all phone calls to keep track of who called 
and determined how to send information to them. Although 12 people agreed to 
participate in the study, only eight people, four men and four women, completed the 
study. As all participants came from the greater Grand Rapids area, there might have 
been concerns regarding previous relationships with me. To ensure that there would be no 
issues in this area, I eliminated any potential participants who were former clients of 
mine. Even though it was a purposive sampling and recruitment fliers were also sent to 
large African American and Latino communities in Detroit and Muskegon, Michigan, 
none contacted me to participate in the study. As Rencher and Wolf (2013) indicated, 
African Americans are often reluctant to participate in research studies due to the feelings 
of mistrust about the researchers and how the researchers will treat them. 
Once interested individuals agreed to be in the study and appeared to meet the 
criteria, I scheduled an appointment for an initial interview. All of the participants 
indicated that they did not have an email address to send information before the meeting. 
To confirm the interview appointments, I called each participant before the scheduled 
interview date.  
Individuals who expressed an interest in participating in the study completed the 
consent form, which I reviewed with them. I delivered the consent form and 




completing the background questionnaire. The signed consent form was collected at the 
time of the initial interview.    To show my appreciation, each study participant received a 
$20 Walmart gift card. 
Research Procedure 
Data Collection: Individual Interviews 
I conducted an in-depth interview with each participant. This in-depth interview 
consisted of open-ended questions. By using open-ended questions, I could consider the 
views, attitudes, and experiences related to older methadone addicts. I recorded all 
interviews for accuracy and clarification. 
Transcripts from the interviews were analyzed for any significant statements 
using NVIVO 11 software, and significant statements were grouped into larger units or 
themes. These themes were then analyzed. I asked the subjects if they would be willing to 
have a follow-up meeting in the event I needed clarification as the data emerged. This 
follow-up was an option and did not limit people from being in the study. The follow-up 
interviews helped me explore themes that developed from the information each 
participant shared during the initial interview phase. 
Initial Data Collection: Background Questionnaires and In-Depth Interviewing 
Each participant signed an informed consent and was instructed to complete a 
background questionnaire. The background questionnaire served as a means to illicit 
descriptive data about each participant and to ensure that each participant was best suited 
to help me examine and explain phenomenon in question. After the background 




interview. Participants were notified on the consent form that the interview would be face 
to face.  
I spent 60 to 90 min conducting a semi-structured interview with each participant. 
The interview consisted of open-ended questions related to the research topic that 
allowed the participants to respond in their own words. Using specific questions and 
probes helped me explore the participants’ responses and descriptions of experiences 
related to the research questions. I recorded all interviews with a digital recorder and 
saved the recording on a flash drive. I also took notes to document any of my perceptions 
and biases related to older methadone users. 
   Questions for the participants were the following: 
 
• What does it mean to be an older person who takes methadone? 
• What types of opiates were you addicted to?  
• How long have you been on methadone? 
• Besides methadone, what other treatment are you using to stay sober? 
• Can you describe any past or present issues that helped you continue your 
recovery from your opiate addiction? 
• Describe the circumstances that led you to decide to discontinue your drug use 
and use methadone.  
• What types of barriers prevent you from accomplishing treatment goals 
established by you and your case manager?  
• How did your addiction impact your relationships with others?    




• What factors do you contribute to shaping these perceptions?  
• How do your family and friends interfere with your treatment program? 
• Do you feel that race, gender, or social status play a role in the services you 
receive for your opiate addiction? 
• Can you identify any health issues that are preventing you from being involved in 
your treatment program? 
• How could treatment providers best serve you therapeutically if you were to seek 
additional services?  
• Are there any other aspects, being your age on methadone, such as views and 
attitudes on help-seeking that have not been explored that you would like to add? 
Interview Procedures 
All participants selected interview sites that were convenient for them to travel to 
with few issues. I conducted the interviews in places near the participant’s home. Half of 
the participants used public transportation or walked to the interview site. Before 
interviewing, each participant read and signed the consent form (see Appendix B) and 
then completed the demographics form (see Appendix C).   
I gave each participant ample time to read the consent form and ask any 
questions. I also reminded all participants that their participation was voluntary and that I 
would treat any information they disclosed as confidential. I asked all participants if they 
wanted a copy of the consent form, but all refused. I kept the completed demographic 
questionnaire and consent form for my records. During the initial interview, I asked 




addiction and methadone use. To show my appreciation, I gave each participant a $20 
Walmart gift card.  
Initial interviews ranged between 60 to 90 min. As stated on the consent form, I 
audio recorded each interview. I secured all information, audiotapes, and written notes in 
a locked cabinet located in my office. As stated on the consent form all information will 
be kept in a secured file cabinet for 5 years after study completion. Except for the consent 
form, I did not provide any other identifying information on any other form, and I gave 
each participant a pseudonym that only I knew. I also kept this information in a locked 
cabinet located in my office.   
In a phenomenological study, the researcher typically uses a long interview to 
collect data on the topic and questions (Moustakas, 1990). As I asked open-ended 
questions, which varied depending on the participant’s responses, time was not the sole 
factor affecting research completion. However, I valued the time of anyone who agreed 
to be part of the study. Therefore, I limited the interview to 1.5 hr, and I met the 
participants at an establishment of their choice.  
Researcher’s Role 
My role as the researcher was to direct the research study toward its established 
goals (Creswell, 2007). For the present study, I strived to gather information about opiate 
addiction and methadone use. I interviewed eight people ages 50–55 years and using 
methadone to treat their opiate addiction. It was important that I assured the questions I 
asked were appropriate and that the questions reflected the information needed from 




as possible. Therefore, I informed all participants of my work as an addiction therapist. I 
further allowed them an opportunity to ask me questions regarding my attitude about 
addiction and older addicts. During the data analysis process, I needed to use the data 
very analytically and as appropriately as possible in order to derive themes from the 
phenomenon of opiate addiction and methadone use (Lien, Pauleen, Kuo, & Wang, 2014; 
Patton, 2002).   
 My main responsibility was to ensure that the participants understood the 
questions asked of them, felt comfortable talking about their addiction and that they 
finished discussing their answers to the questions at their own pace in order to bring 
about the best possible and most usable answers. Although I may have some perspectives 
regarding methadone use, it was also important for me to realize that the participants had 
important information that must be explained and analyzed in order to accurately 
interpret the results. In addition to recording the information, I took notes and listed such 
issues as facial expressions, body language, and other nonverbal expressions that helped 
me interpret the data. 
Transcript Preparation 
I used a transcriptionist who has had confidentiality training to transcribe the 
interviews and to ensure participant confidentiality. The transcriptionist was identified in 
my application to Walden University’s Institutional Review Board. The transcriptionist 
signed a confidentiality statement, agreed to keep all interview data confidential, and 
agreed to delete and/or destroy all electronic or paper copies of the transcribed 




confidentiality as the transcriptionist did not know any of the participants. In addition, I 
ensured accuracy by using the digital recordings to review each transcription. This also 
provided another means of data immersion.    
Recorded information from the present study was limited to only those who 
needed it; that is, the transcriptionist, my dissertation committee, and myself. The signed 
consent form notified participants that their information will be held in confidence. All 
information was kept at my office in a locked file cabinet. Participants’ real names were 
only kept while the data were being collected and were separated from any of the data 
collected. In keeping with Walden University regulations, I kept copies of the participant 
list separate from transcribed data in my office in a locked file cabinet. The audio 
recordings were erased from the flash drive after the transcripts were completed and 
checked for accuracy, pauses, or emphasis.     
Data Analysis 
I used a modified form of the Stevick-Colaizzi-Keen method (Moustakas, 1994) 
for data analysis. This method consists of the following six steps:  
1. I began with a full description of the personal experiences of the participants 
concerning the phenomenon. 
2.  I developed a list of any significant statements.  
3.  I grouped the significant statements into meaning units or themes.  
4.  I wrote a textural description.  




6.  I wrote a composite description of the phenomenon incorporating both the 
textural and structural descriptions (Creswell, 2007).  
In addition, my committee chair and methodologist reviewed the material with me to 
assure the accuracy of my assessment and theme building.   
Themes 
Themes were generated from identifying significant statements in the interview 
transcripts or other forms of data. These significant statements dealt with how individuals 
experienced the phenomenon being studied. After this process was completed, the 
significant statements were gathered in larger units of information known as themes 
(Creswell, 2007). For the present study, themes were established through identifying each 
participant’s significant statements. I used NVivo 11, a qualitative data analysis program, 
to verify groupings of codes and to put them into nodes. I organized each theme area into 
one of three domains: views, attitudes, or barriers. These areas were used as salient 
themes for the study if at least five of the participants have experienced relating to the 
identified theme area.  
I connected any relevant portions of text to nodes in the NVivo program. As this 
process was evolving, I deliberated on the meaning of each significant text and made 
decisions as the text related to the study’s essential themes. NVivo 11 allowed me to 
review all of the text and organize the document into a final thematic analysis. The 
summary of the information gave me a detailed account of supporting text for each item, 





Bracketing, also known as epoche, is the process where the inquirer removes his 
or her experiences, as much as possible, in order to take a nonbiased look at the 
phenomenon in question (Moustakas, 1994). This is a major step in conducting empirical 
phenomenological research. The goal of bracketing was for me to set aside my 
experiences so that I could be as neutral as possible. Several researchers described 
phenomenological reduction or what Husserl defined as bracketing (Jones, 1975; Klein & 
Westcott, 1994; Polkinghorne, 1983). Husserl saw bracketing as identifying any personal 
biases while observing the outer world so that contact with participants can be 
successfully achieved. I delayed my decisions or particular ideas regarding the 
phenomenon in order to have a clearer understanding of it. Jones (1975) encouraged 
researchers to expand their understanding of bracketing beyond postponing their beliefs 
about the phenomenon in order to create some skepticism to help expose themselves to 
the study. Though Husserl acknowledged the unusualness of this position, he continued 
to support it as a viable pursuit (Edie, 1987). 
Moustakas (1994) stated that postponing one’s belief is never truly reached. One 
way in which I demonstrated the bracketing process was by including a description of my 
own experience with the phenomenon and bracketing out my view prior to moving 
forward with the lived experiences of others, as suggested by Creswell (2007). I informed 
all participants of my work as a substance abuse therapist and acknowledged any 




Establishing Credibility of Qualitative Data  
Immersion 
In phenomenology research studies, the immersion process is in place from the 
onset of the research through the completion of the study. Immersion began when I used 
my experiences to develop opinions about the phenomenon being studied. The immersion 
continued by my reading related literature to explore the topic and gain a deeper 
understanding as a whole. For example, my experiences with older methadone users who 
are dealing with legal issues, family problems, relapse, and cravings who feel they are 
unable to access treatment due to stigmas about opiate use prompted me to look for 
previous research on treatments for opiate users. I asked participants about their views, 
opinions, and any barriers they faced accessing treatment. Exploring treatment issues that 
older methadone users face helped me develop interview questions that were situated in 
the context of the literature and that spoke to the daily lived experiences of this 
population. It was my hope that the participants’ voices were not lost and that their voices 
help shape the direction and content of the services that older opiate addicts need. 
Member Checks 
Member checks require presenting the findings and/or interpretations of the 
findings through descriptive triangulation, which creates consistency between the 
participants and myself (Leech & Onwuegbuzie, 2007). Member checks are considered 
one of the most critical techniques for establishing credibility in qualitative research 
designs (Lincoln & Guba, 1985). Member checks was instituted in the present study by 




from the initial interview. This gave participants an opportunity to comment or correct 
any information that had been gathered. Although member checks are strongly 
recommended to ensure data trustworthiness, Carlson (2010) advised beginning 
researchers to be cautious prior to carrying out this procedure. Carlson further 
encouraged placing any relationship between the researcher and participants up front to 
ensure the validation process. Carlson also warned that giving participants large amounts 
of information could be overwhelming, especially if any participants have difficulty 
comprehending the information.  
Research Auditor 
The research auditor serves as a mechanism for analyzing the study. The auditor 
assists in “keeping the inquiries honest” (Lincoln & Guba, 1985, p. 243). The auditor 
may also serve as a source of new ideas or perspectives that will help the researcher see 
the bigger picture at hand (Lincoln & Guba, 1985). For the present study, the research 
auditor, a member of my dissertation committee, reviewed the initial interview transcripts 
for each study participant. The research auditor also used the data to identify the salient 
themes that were consistent across the participants. This helped determine if the themes I 
identified were evident to an outside researcher. The auditor was also trained in 
confidentiality protocol and signed a confidentiality statement agreeing to keep the 
content of all of the interview data confidential and to delete or destroy all electronic or 





According to Merriam (1998), transferability or external validity concerns the 
extent to which study findings can be applied to other situations in a different time or at a 
different place. Merriam further noted that transferability indicated that the research will 
be applicable or that similar findings for similar participants could be found. 
Transferability is also a direct function of the similarity between two contexts known as 
fittingness. This idea can be defined as the level of congruence between sending and 
receiving contexts (Lincoln & Guba, 1985, p. 124). To demonstrate how this 
phenomenon was practical in application to the present study and in other settings, 
discussions were provided on how the study was situated in literature, who the 
participants were, the chosen methodology, and data analysis.    
Triangulation 
Triangulation improves the study’s legitimacy by evaluating the honesty of the 
interpretations that the researcher draws from more than one vantage point (Lincoln & 
Guba, 1985). According to Denzin (1989), triangulation involves using additional data 
sources, researchers, different theoretical perspectives, or several methods combined.  
With regard to triangulation, I sought data from multiple sources, methadone users from 
three different locations through multiple methods (semistructured initial and follow-up 
interviews and field data). This provided a more detailed and balanced explanation of 
lived experiences of older methadone users. Furthermore, immersion in related literature 




patterns with existing literature helped me make meaning of what is similar and different, 
and why, thereby increasing my understanding of the investigated phenomena. 
Validity 
 Validity describes a measure that accurately reflects the idea it is intended to 
measure (Babbie, 2010). Validity is also defined as “the best available approximation to 
the truth of a given proposition, inference, or conclusion” (Trochim & Donnelly, 2008, p. 
20). Qualitative validity involves the researcher checking for findings accuracy by using 
certain procedures that accept the reliability of the research by testing it against previous 
research (Creswell, 2009). To verify that the findings in the present study represented the 
experiences of older opiate users, I agreed to share the research findings with study 
participants. I also agreed to make revisions if any participants indicated that I failed to 
identify their perceptions of their lived experiences as older methadone users.  
Trustworthiness involves ensuring that study outcomes are credible or acceptable to the 
people involved in the study (Trochim & Donnelly, 2008). As the present study’s purpose 
was to explain or recognize the phenomenon from the participants’ point of view, 
participants were the only ones who could determine the study’s trustworthiness and 
credibility. 
One threat to validity is research bias, where the researcher may place his or her 
expectations into a study (Isaac & Michael, 1997; Maxwell, 1996). The concern is that 
the researcher’s bias and expectations may invalidate the study results. One bias in the 
present study was a concern that I do not have a history of opiate dependence and 




family; as such, I have firsthand experience of what addiction does to family members.  
Therefore, I may have made assumptions as to whether or not addicts may have healthy 
and appropriate lives without relapsing to their drug of choice.   
Summary 
To summarize, in Chapter 3 I provided an overview of the research methodology 
employed in the present study. My discussion included hermeneutic phenomenology, the 
specific approach taken, and the qualitative paradigm employed. I also discussed study 
participants and the methods that were used to recruit the participants. My role and 
worldview were also discussed. In Chapter 4, Iwill discuss results from the information 




Chapter 4: Results 
The purpose of this research study was to provide a description of the experience 
of older methadone users. The research objectives were fourfold: (a) to acquire an in-
depth understanding of the phenomenon of older methadone users, (b) to elucidate and 
describe participants’ experiences of addiction and treatment using their own voices and 
perspectives, (c) to extract and develop themes from the data, and (d) to interpret 
participants’ lived experiences and meaning constructions in an addiction-related 
theoretical framework.   
In Chapter 4, I presented the findings of the lived experiences of older methadone 
users and their views, attitudes, and barriers regarding using methadone for their 
addiction. As will be seen in their discussions of their experiences, participants talked 
about their thoughts on needing methadone, having relationships with others due to their 
addiction, attitudes about using methadone and their opiate addiction, and stigma as it 
related to being an older opiate addict needing methadone. The collective core of the 
participants’ experiences concerning help-seeking was examined to uncover common 
themes in the participants’ individual narratives. By analyzing each participant’s 
narrative through a phenomenological analysis structure, I established certain themes.   
Chapter 4 begins with an overview of participant demographics and biographical 
sketches of each participant. This is followed by a discussion of my findings, including 
the identification of five qualitative themes that emerged from the data analysis process. I 
recorded all interviews with a digital recorder and had all of the information erased once 





This section includes descriptions of study participants. All demographic and 
biographical data are presented and discussed as being current at the time of the study. 
All participants were involved in a methadone clinic and were using methadone on a 
daily basis. All but one relied on public funding to pay for their methadone, and most 
were not involved in other treatment programs to help in their recovery. Two participants 
knew each other, and I omitted all personal information that could make them identifiable 
in the following descriptions. Participants were assigned pseudonyms to protect their 
identities. Table 1 shows participants’ demographic information.  
Table 1 
Participant Demographics 
Participant Age Marital status Race Gender Education 
Nancy   50 Single White/NA Female Some high school 
William 54 Single White Male Some college 
Elizabeth 53 Divorced White Female High school graduate 
Danny 55 Single White Male High school graduate 
Anna 55 Single White Female College degree 
Bernice 50 Single White Female High school graduate 
Rex 53 Married White Male High school graduate 
James 55 Single White Male High school graduate 
 
 
Table 2 shows data related to the participants’ time involved in the methadone clinic, the 
















Nancy   7   7 135 mg Yes 
William   2   2 120 mg No 
Elizabeth   2   2   90 mg Yes 
Danny   4   2 125 mg Yes 
Anna   5   5 145 mg No 
Bernice   6   6   85 mg No 
Rex   8   8 133 mg No 
James 22 20 165 mg Yes 
 
Nancy 
Nancy is a 50-year-old single biracial female who reported being involved in 
methadone treatment for the past 7 years. She stated she lives alone in a subsidized 
housing unit and receives Supplemental Security Income (SSI). She reported using a 
variety of opiates, including heroin, and has been an intravenous (IV) drug user. Her 
involvement with drugs began with a former boyfriend. She stated that her low self-
esteem prevented her from saying no when her former partner encouraged her to use 
drugs. Nancy reported that to help her eliminate her addiction to opiates in the past, she 
was involved in residential treatment three times and used Suboxone for 1 year. She 
reported she stopped taking Suboxone due to its cost and not getting the public funders to 




 Nancy stated that her reason for using methadone was that she was “sick and tired 
of being sick and tired.” She acknowledged that she engaged in many different activities 
to support her drug habit and had to deal with both shame and guilt. She expressed how 
she felt that being a female impacted the services she received and stated that the nurses 
do not believe that women are clean if they wear makeup. She voiced a commitment to 
staying sober and not returning to opiates in the future. 
William 
 William is a 54-year-old White male who said he had been involved with 
methadone for the past 2 years. He stated that he lives alone in an apartment and is 
employed full time. He reported using Vicodin 10 mg, pills and Percocet 10 mg pills as 
both were easy to obtain on the street as well as snorting heroin. He acknowledged using 
these drugs until he became high.  According to William, his history of using opiates 
began in his mid-30s when he started associating with friends who were using opiates.    
William stated that his primary reason for using methadone for his opiate 
addiction was that he was “sick and tired of being sick and tired,” but mostly tired of 
chasing the drug and then getting caught. He also reported that he engaged in some illegal 
activities to support his drug habit but did not want to talk about that part of his life.  
Although he did not see his race or gender impacting his methadone treatment, he 
reported feeling that some of the staff treated some of his minority associates differently 
than him and some of his White associates. William stated that importance of being 
involved in treatment was to let everyone know that addiction is a disease and that it 





 Elizabeth is a 53-year-old single White female who stated she had been involved 
with methadone for the past 2 years. She stated she lives alone and is employed part time 
to help supplement her SSI. She reported using morphine and Fentanyl for her cancer 
treatment and later began misusing her medications. Before using methadone, she said 
she was involved in outpatient and residential treatment. She also acknowledged trying 
Suboxone but said she stopped because it did not relieve her cravings for opiates.    
 Elizabeth stated that her reason for using methadone was that she needed it to 
remain sober while trying to treat her cancer. She indicated that due to her addiction she 
became involved in the criminal justice system and spent 3 years in prison. She 
acknowledged that she spent money earmarked for household expenses to support her 
drug habit. She also reported that because of her addiction, and her history of being an 
enabler, she is unable to have healthy relationships or be emotionally close to other 
people. Elizabeth expressed concern that treatment providers do not do enough to 
eliminate or change the stigma of being on methadone and that there needs to be more 
education about the need for methadone clinics due to seeing too many of her friends 
dying from their drug use.     
Danny 
 Danny is a 55-year-old single White male who had been involved with methadone 
for 4 years. He reported he lives by himself in an apartment and works to support himself. 
He reported using a variety of opiates such as Tylenol 3 and 4, Vicodin 10 mg pills, and 




began using heroin after he developed a high tolerance to these opiates and that he has 
been an intravenous drug user. Danny reported that he was previously involved in 
residential, intensive outpatient, and traditional outpatient treatment programs to address 
his addiction. He stated that he started using opiates after he became involved in the 
criminal justice system. He also admitted that he had to deal with some depression and 
felt that his drug use helped him overcome this problem.   
 Danny said his reason for using methadone was that after being involved in the 
criminal justice system for the third time he was motivated to stay out of jail. He stated 
that he supported his drug habit by using his income and later engaging in some illegal 
activities. He reported that he did not feel his gender or race impacted his treatment 
experience. He reported that he wants to remain sober, and his goal is to wean himself off 
of methadone. 
Anna 
 Anna is a 55-year-old divorced White female who had been involved with 
methadone for 5 years. She said she lives with a roommate who also attends the 
methadone clinic, so they try to keep each other accountable. Because of her medical 
issues, Anna reported that she is unable to work and receives SSI. She stated that her 
drugs of choice were Fentanyl patches, heroin, hydrocodone 10 mg, and morphine, but 
that she was never an intravenous drug user. Anna acknowledged that she sees a therapist 
on a weekly basis in an outpatient clinic to help her substance abuse treatment. She said 
her drug use began as she was involved with someone who was using different opiates. 




with various opiates. She stated that once she decided to stop using opiates she had to be 
hospitalized due to the physical impact of her withdrawal.   
 Anna indicated that her medical issues from withdrawing from opiates were the 
impetus for starting on methadone. She admitted she was “sick and tired” of using opiates 
and the impact they had on her life. She reported that she lied to relatives and friends to 
get money to support her habit. Anna stated that her gender or race has not impacted her 
ability to receive services, but felt there were times people at the clinic did not make her 
feel welcome. Anna said her primary goal is to remain sober and not use again. She also 
expressed concern that society is starting people out on methadone too soon. She would 
like funding for more outpatient and residential treatment programs before starting 
younger people on methadone.  
Bernice 
 Bernice is a 50-year-old single White female who has been involved with 
methadone for 6 years. She stated that she is not employed and receives SSI to support 
herself. Bernice reported using a variety of opiates, including heroin, hydrocodone 10 mg 
pills, and methadone 5 mg pills, all of which she stated she obtained off the streets, but 
said she has never been an intravenous drug user. Bernice reported previous involvement 
in classes to help her understand her drug history. She also said that she would begin an 
intensive outpatient treatment program soon. She said her opiate use began to help her 
with pain management and said that part of her reason for using methadone is to help her 




 Bernice stated that her reason for using methadone was two-fold: pain 
management and she too was “sick and tired of feeling sick and tired.” When she began 
using opiates, she was working and supported her habit by using her income. She also 
reported stealing from her family, and this behavior caused some strains in her 
relationship with family members. Bernice said her gender or race has not impacted her 
ability to receive services for her opiate addiction, but at times she felt that clinic workers 
did not treat her with dignity and respect. Bernice stated that her goals are to remain 
sober, improve her relationships with her family, and begin developing a relationship 
with her grandchildren. She also stated that she would like to be treated with dignity and 
respect and feels that due to being an older person addicted to opiates she is not. 
Rex 
 Rex is a 53-year-old married White male who has been involved with methadone 
for 8 years. He stated that he lives with his wife and their children in an apartment and is 
employed. Rex reported using a variety of opiates such as heroin, OxyContin, and 
Fentanyl patch. He also admitted a history of IV drug use. Rex stated that he had no 
previous treatment experience before starting methadone. He has been involved in NA 
but reported no sponsor or other support. Rex’s opiate use began as a way to manage 
some pain, but it got out of control. He stated that he has also had to deal with some 
losses in his life, and the opiates temporarily addressed his depression.   
 Rex said his reason for starting methadone treatment was that his son told him 
that unless he got help, Rex would not see his granddaughter. He also stated that his wife 




his income to support his habit in the past and did not pay his bills. He said that he did 
not feel his gender or race impacted his treatment experience. He stated that his goal is to 
remain sober and improve his relationship with his family.   
James 
 James is a 55-year-old single White male who reported being involved with 
methadone for 20 years. He lives with friends, one of whom is also using methadone to 
maintain his sobriety, and they support each other. James reported using a variety of 
opiates such as heroin, OxyContin, 80 mg, morphine, and Demerol, 50 mg which he took 
from people who were taking the medications for their pain management. He has also 
been an IV drug user. James admitted that he has been in residential and outpatient 
treatment to address his opiate addiction. He stated that he began using opiates as he 
wanted to be part of the crowd at the time and found that he could not stop.   
 James said he began using methadone for his opiate addiction after he saw several 
friends die from an overdose and realized it could happen to him. He also stated that he 
was “sick and tired of being sick and tired.” He said he was tired of using needles and 
sick of the behavior he engaged in to support his habit. James stated that he supported his 
habit by using his income and hustling others for money for his addiction. He stated that 
he did not feel his gender or race impacted his treatment experience. He said his goal is to 
remain sober and wean himself off methadone. 
Themes Derived From Data Analysis 
The purpose of this study was to explore the experiences of older addicts and their 




formal interviews, I used van Manen’s (1997) selective highlighting technique. This 
particular data analysis approach allowed me to identify key portions of the text and 
highlight them to find specific themes. Initially, text highlighting was done in the 
transcriptions, but I also highlighted the salient text in NVivo 11 during the final data 
analysis.   
As the data analysis process unfolded, I identified certain thematic statements for 
each distinctive meaning that I discovered in the transcripts. Van Manen (1997) indicated 
that themes are statements or thematic statements that sum up each major portion of the 
text and that present a special facet to the overall understanding of the phenomenon. Van 
Manen saw their development as being distinctive in qualitative methods. Using NVivo 
11 allowed me to link significant text with essential themes. This process of linking 
themes that NVivo 11 recognized further illustrated the iterative nature of theme 
development. Each time I reviewed the transcript, I found new linkages and expanded my 
perception of each essential theme.   
After completing my analysis, I identified five main themes: relationships with 
others and how methadone has impacted these relationships, attitude of being an older 
methadone user, mental health stressors related to being an older methadone user, 
attending the methadone clinic daily, and needing other treatment besides methadone to 
address their opiate addiction. Table 3 shows the complete list of the themes, the number 
of sources each theme came from, and the number of times each theme was referred in 
the participants’ discussion. Themes were derived from eight interviews. All participants 





Final Themes With NVivo 11 Data Analysis Summary Demographics of Participants 
Themes 
Number of sources 
from which each 
theme was derived 
Number of references 
across all sources 
Relationships with others and how 
methadone has impacted these 
relationships   
8 16 
Attitude of being an older methadone 
user 
8 20 
Mental health stressors related being an 
older methadone user 
8 22 
Attending the methadone clinic daily 8 36 
Needing other treatment besides 




The following sections include the interview content that related to the major 
themes. Throughout these sections, quotations are used as evidence of the themes. These 
quotations are not meant to serve as exhaustive examples of the influential factors that 
were shared during the interviews. Instead, the quotations are intended to give the reader 
a flavor of the thoughts the participants had about their lived experiences regarding 
methadone use and some of the actual experiences that motivated them to get sober or 
made it difficult for them to maintain their sobriety. The quotations serve as a textural 
description of the participants’ lived experiences. The quotations that detail actions that 
were taken or how different behaviors were manifested in their lives serve as a structural 
description of their lived experiences. The collective narrative summary was constructed 




Methadone’s Impact on Participants’ Relationships with Others   
Several study participants shared concerns about how their addiction has affected 
their families, especially their children and grandchildren. All participants spoke to the 
point that they, like other people, are human and have flaws. There was a concern that 
due to their addiction, others saw them as being extremely weak and unable to resolve 
issues in their lives. This idea appeared to be especially true for the male participants. 
Danny spoke openly about his struggles with opiates and needing methadone to remain 
sober. He stated that others had indicated to him that people who need methadone, 
particularly older adults, were simply trading one drug for another.  
My family and friends do not know that I am taking methadone. I feel they would 
see it as me just using another drug. I won’t tell my family that I am using 
methadone until I am using less so that they won’t judge me. When I became 
addicted to OxyContin, and I was struggling to try and get sober, my family and 
some friends did not want me around. Their view on addicts was that I would 
steal from them to support my habit. I couldn’t tell them that I was hurting both 
physically and emotionally as I felt they abandoned me.  
Bernice provided information suggesting that she received mixed support from 
her family and friends due to her involvement with methadone. She spoke of how some 
of her family supported her being on methadone while others felt that she needed to end 
her dependency on other drugs. 
Some of my family thinks that it is good that I am using methadone to treat my 




drug for another. They thought when I was hurting, I should find a way to suck it 
up and be strong. I was a wife and mother and wanted to be there for my family, 
but could not find a way due to my drug use.  
Anna, who has been struggling with her addiction for over 20 years, stated that it 
was difficult for her to be open and honest with her family about her addiction, especially 
being a female.  
My family treats me like I am still on street drugs. If my family sees me using 
methadone, they treat me like I am no good. They said that if I wanted to stop 
using drugs, I would get off with no problems. They also saw methadone as being 
something that is short term and don’t understand that without methadone I could 
return to my drug of choice. Because I am a woman, I am supposed to know 
better and should be the caregiver for others and not have others take care of me. 
Nancy, who spoke of her concerns about needing methadone to stay alive, shared 
how her family blames her for other family members becoming addicted to drugs and 
stated that her relatives wish she did not use methadone. 
My mother and other relatives hate me being on methadone. They do attach a 
stigma to being on methadone. My family blames me for my daughter and others 
becoming addicted to drugs and needing methadone. Some family members think 
that I am using methadone as a way to continue my drug use and get high. 
When Elizabeth spoke about the importance of family, she talked about it from a 
self-need approach. As a person who was involved in the criminal justice system due to 




Some of my family members see people using methadone as being IV drug users. 
When I struggled in the past, I could not be honest with them for fear of being 
rejected and ostracized. I had to find treatment on my own and be able to answer 
their questions about addiction. I found it necessary to pull back from others for 
some time to reflect, refocus, and reenergize to continue working on my recovery. 
William also indicated that his family does not support him needing methadone to 
work on his recovery. He further indicated that he did not seek support from his family 
for his recovery and reported that he is on his own when he works his recovery.  
My family sees me using methadone as a way of getting high. They think that I 
should just be able to stop on my own. I don’t get my family and others involved 
in my treatment, I work it by myself. I don’t think they understand the pressure 
and that comes from me trying to be sober. My family is unsure what to say or 
how to help at times, but continues to tell me not to use. 
There were two exceptions to this position. James indicated that he receives a 
great deal of support from his family but not his friends. He indicated that his family 
supports his recovery efforts but stated that he has hidden his issue from some of his 
friends.   
My family is all for me using methadone to stay sober and not return to my 
previous behavior. My family is also very supportive of my treatment, especially 
my mother. I know that if I did not have her support, I would become upset and 
probably use again. I have not told my friends about me using methadone because 




categorize being on methadone as hanging out with other drug addicts and not 
doing anything about my life. I don’t think they understand the need to be on 
methadone and that my addiction is a disease. When it comes to people other than 
my family I feel that I am fighting a losing battle trying to get them to understand. 
Rex indicated that he receives support from his family and friends as it relates to 
him being on methadone and not using.  He acknowledged that he seeks his family and 
friends’ to help him remain sober.   
My family and friends are okay with me using methadone. They saw how I was in 
the past and feel that methadone has had some positive effects on me. The people 
who don’t know about how methadone works are uneducated about addiction and 
its impact on people’s lives.  
All study participants provided examples of their humanness and how others find 
it difficult to view them as being less than human or not having others accept them as 
they are. This common theme speaks to the need for older methadone users to have 
healthy relationships with family and friends without feeling that others are judging them 
or placing unrealistic expectations on them.  
Attitudes Related to Being an Older Methadone User 
 Participants’ attitudes appeared to be mixed relating to older opiate users needing 
to be on methadone. Several of the women interviewed had a negative attitude about 
being on methadone at their age while most of the men reflected a positive attitude.  
Nancy reported feeling upset that no one talked to her about how long she would 




I wished someone had warned me about the ultimate downfall. I would have 
never started using methadone had I known that I would be on it forever. I would 
have loved it if they had advised me about why I needed methadone for as long as 
I have taken it and I might have changed my mind. 
  Nancy also spoke about the physical and emotional rollercoaster she felt being 
on methadone. She acknowledged that despite needing methadone to maintain her life, 
she was unhappy about depending on it, and said, “I wished someone would have warned 
me about the withdrawals when methadone wears off, I would never have started using 
it.”   
 Even though Bernice acknowledged that it has been hard for her to remain sober 
in the past, she has problems with not being able to eliminate her need for methadone.  
To me methadone is more addicting than other drugs, and I wish I had never 
started it. I feel like being on methadone has made me age more and sometimes I 
feel that this drug should be for younger people.   
William also acknowledged his displeasure about needing to take methadone.  
Even though I need it to help deal with my physical pain, I do not like being 
dependent on methadone. I wish that they would counsel you or tell you about all 
that it takes to maintain your sobriety while, on methadone, I may have made a 





 Danny indicated mixed feelings about being on methadone. He spoke about his 
struggles being an addict for as long has he has been, but also the importance of being on 
methadone.  
 Methadone makes me feel like I have lost a lot and now it is catching up to me. 
Methadone has also helped me stay straight. I see methadone as a tool to get the 
most out of myself and it has also helped treat my chronic pain. 
 Anna also expressed some mixed feelings about being on methadone. She saw 
methadone as a lifesaver but also a curse.  
Methadone has saved my life and I may have been dead without it, but it has also 
put some serious stress in my life. When I don’t take the methadone, I will go 
through some significant withdrawal. I need to go to the clinic daily to get my 
dosage and I hate it. I can’t go anywhere due to needing to be dose daily.  
 Others expressed a more positive attitude about the importance of being on 
methadone at their age. Elizabeth stated that as she has an addictive personality, and  
recognizes the need to take methadone.  
I am grateful to this means of treatment, especially for someone my age. I have 
tried other medical treatment, including Suboxone, but I had trouble transitioning 
and eliminating other opiates out of my system when taking Suboxone. 
Methadone was the only medication that has worked for me. 
 Rex stated that it is difficult for someone his age to connect with other people of 
similar ages and with similar experiences who have also struggled with opiate addiction 




content and can be more active in society. Methadone has helped me reconnect with my 
family as I am now more involved with my family.” Rex stated that before taking 
methadone, he felt as if he was alone at times as an addict and that others would not want 
to be around him or want him around their family. 
 James also acknowledged that at his age he struggles with feeling alone in his 
battle with his opiate addiction. He said, “I would rather be on methadone than be out 
hustling. At my age, I can’t do what I did in the past, so taking methadone has saved my 
life.”  
 Five participants directly expressed issues with taking methadone at their age.  
One participant who reported not having a problem being an older methadone user at her 
age said she felt it important to use whatever tool is available to overcome one’s 
addiction. The importance of her needing methadone was still evident in her response to 
trials in her life. 
Mental Health Stresses 
 As older methadone users, many participants expressed that there were certain 
stressors and experiences that came with being on methadone. The areas of life that were 
affected the most varied in intensity and frequency. Participants who shared concerns 
about stressors and experiences indicated that others cannot comprehend the gravity of 
maintaining their recovery.   
 For Nancy, the mental health stressors and experiences related to being an older 




daily basis. She spoke openly about the emotional ups and downs that she has to address 
while trying to help her daughter balance her emotional state.   
During different times when I was struggling with some of my issues, I could not 
address them as my daughter would call me upset because of problems with her 
boyfriend. I know that I have a co-occurring disorder and it is difficult for me to 
talk to others about my issues. I find it difficult to trust others because I have been 
burned so many times in the past. We do need help with our self-esteem for using 
methadone at our age. 
 Elizabeth shared how her mental health problems are related to her poor 
relationships with others.  She also indicated that being over 50 years of age and knowing 
that she needed to make changes in her life has caused her some mental health problems.  
When you feel like you let others down you begin to feel some stress and realize 
there is no magic wand to fix your problems. A lot of times older addicts are 
misunderstood and so it becomes quite stressful. There are times I feel that trying 
to maintain my sobriety can feel overwhelming and I need to find someone I can 
talk to.   
 Saying no to others has been a major mental health problem for Anna.   
For many addicts, including myself, we want relationships with people who 
understand us so we hang out with the wrong people. As I want someone to like 
me, I am willing to do nearly anything. I feel that if I don’t I won’t have anyone 
who will like me. I become depressed when I say no and I become depressed 




use. Being an addict I feel that others may judge me for my past behaviors and not 
want to listen to my story.   
 Bernice also shared how being an older methadone user has caused her some 
mental health issues and feelings of depression. She acknowledged that she has found it 
difficult to share with others and that she feels that when she needs to talk, people will 
find all sorts of excuses not to be there for her or do not have the time or want to engage 
with her at an intimate level.  
You can always try to get some help from somewhere, but a lot of people look 
down on you for that. Some people think we should know better, but it would be 
good to get help from others. It becomes a problem so you feel like you are all by 
yourself.   
 Danny also acknowledged that he struggles with depression, but stated that he 
turns to his faith to help him through his problems. He said, “For me when I feel down, I 
go to church and try to retain my faith in God.” He shared a personal experience of seeing 
someone overdose and struggling internally as he could have done more to help his friend 
or look for signs that his friend was in trouble.  
I was devastated when my friend died, but did not know how to deal with it 
except continuing to use. There was a definite weight of having to come to terms 
with being an older addict when you see someone die from doing the same thing 
you do. I think one of the challenges for us an older addicts is to recognize the 
mental health problems within yourself. You see others misbehaving and you 




Older addicts face many mental health stressors on a daily basis. Five study 
participants shared examples from their lived experiences that have affected them as 
being an older person needing methadone. All of the women in the present study reported 
some form of a mental health problem related to being an older methadone user that 
could speak to the added stress of being an addict. Danny shared the emotional loneliness 
that he experienced for not feeling that he connected with his family and how some 
turned their back on him when they learned he was addicted to different opiates.  
 Although all participants expressed concerns about not being viewed as a human 
who has hurts and pains, most admitted that being seen simply as an addict has not 
allowed them to openly display their hurts and troubles. There was an inherent pressure 
of at least appearing healthy because they struggled to find emotionally safe people they 
could confide in.   
Attending the Methadone Clinic Daily 
 Having to attend the methadone clinic daily to obtain their methadone was an 
issue evident throughout many participants’ narratives. Not being able to have a normal 
life was not lost in this collection of older methadone users. For the participants in this 
study the inability to spend significant time with family and friends affected them having 
a normal life. Several participants spoke of being fearful of being penalized if they 
missed time at the clinic.   
 Anna was very outspoken about having to go to the clinic on a daily basis for her 
methadone. She expressed frustration about not being able to spend time with her father 




I wished that we could find other ways to get our dosage. I feel as if I am chained 
to the clinic and I cannot go anywhere for a significant period due to needing to 
go the methadone clinic every day. I would like more of a life.  
 Bernice talked about feeling embarrassed having to go to the clinic and get 
permission from others to feel better. She explained that she felt that the clinic staff and 
others may treat her like a child and said, “I sometimes feel like they treat me as a child 
and not as an adult.” Bernice spoke of her frustration of having to get herself ready to go 
to the clinic every day along with the stigma of being seen at the clinic. She indicated that 
due to her physical problems she struggles to have to go to the clinic every day and said, 
“I would like to get methadone from my medical doctor as he has a better understanding 
of all of the medications I need for my life.”   
 Elizabeth expressed how she felt the system does not trust her by requiring her to 
come to the clinic daily.  
I know that there are consequences if I was to relapse. Making me come to the 
clinic every day does not guarantee I won’t do anything I shouldn’t do. I need to 
do be able to do other things with my life besides worrying about getting to the 
clinic every day. 
 For James, going to the clinic daily was very troublesome. As he does not have 
his own transportation he has to rely on people to get him to the clinic and does not like 
how others look at him being an older user. 
Even though my family wants me to get and stay sober, I know that they get 




for a ride and wish that I could feel like I have regained their trust. I feel people 
look at me differently because I am much older than what others expect people 
who are addicts look like who use methadone.  
 Nancy also felt that going to the clinic daily at her age made her feel that the staff 
did not trust her. She also talked about the difficulty of her family believing that she 
needs to attend the clinic daily.  
Trust is an important issue for me and when I have to go to the clinic daily, I feel 
as if I am being put down for being an older addict. Even though my family sees 
methadone as medicine, they don’t see why I have to go every day as other 
people needing medicine are able to get it and go home.  
 William talked about how having to attend the clinic daily affects his ability to 
work. He indicated that he would like to have a normal life and be able to show others 
that he can care for himself. For him attending the clinic daily prevents him from being 
able to work overtime or different schedules. He said, “I would like to work first shift or 
get promoted, but I can’t because the times I would have to work would interfere with me 
getting my meds.”  
 Six participants shared their frustrations about going to the clinic on a daily basis.  
These participants all shared their negative experiences that spoke to them having to 
ensure that they will not misuse their medication. The need to attend the clinic daily 
appears to add to the stigma of being an older methadone user and the feeling of being 




Needing Other Treatment Besides Methadone   
 The need for additional treatment services for older and younger opiate addicts 
was not lost on study participants. Participants stated that for additional treatment to take 
place it was important that those who fund the programs understand and see that 
methadone by itself is not a cure for people’s opiate addiction. Some participants 
identified what they felt would be appropriate treatment modalities for older opiate users. 
 Additional treatment for Nancy centered on the ability to find someone she could 
trust. 
 I need to talk to someone about some of my past issues that contributed to my 
addiction. My problem is that I have tried counseling in the past, but I have felt 
betrayed by some people. “I know that other addicts and I need more than just our 
daily dosage, but I am not sure how to go about getting it.”  
She also indicated that therapists need to talk to clients about the clients’ needs and not 
assume that as the therapist they know everything.  
 Elizabeth expressed her gratitude for being able to talk to someone about her 
problems and other issues that did not solely include using methadone. 
Treatment providers in the community have knowledge of additional resources for 
addicts. Working with a case manager, I was able to get decent housing. The other 
thing is that I know there is someone who will hold me accountable if I make a 




Elizabeth said that one thing that helped her talk to her therapist was knowing that the 
therapist was duty bound to keep the secrets of others, which made her feel safe talking 
about issues that she did not feel comfortable sharing with family and friends.   
 Outpatient treatment is something Anna values and has used to deal with some 
significant problems in her life. She shared how in most instances she needed someone 
who forced her to talk and share thereby helping her overcome past issues. 
For me it has been difficult to share and I know that I have some issues from my 
past that need to come up. If they don’t I could use again. I need a person who 
will push me to talk more about my addiction and what I went through. I need to 
talk about what I lost and if I go astray, they need to hold me accountable. 
 Bernice stated that involving older opiate users in additional treatment is 
imperative for their recovery. When asked what she could get out of therapy she said it 
would help her improve her self-esteem.  
I know that I have a lot of past issues that have impacted my life. I have been 
feeling depressed for a number of years and need to find out why so that it does 
not continue to cause me to want to return to using again.   
For Bernice, treatment centers on feeling safe and being able to share. She also stated that 
being able to talk and speak out about her life helped ensure that she does not return to 
some old negative habits.  
 James said he is aware that treatment besides methadone would help him in his 




I know that I need other treatment as it will help keep me sober. I am selective 
about what I will use as I need to know that I can trust the person or the program.  
I would like to find someone near my age who also has experienced issues with 
addiction. I need to know that they can understand what I have gone through.  
Five participants provided specific reasons for being involved in additional 
treatment. The most common themes were working with a therapist who is empathic, 
who will treat them with dignity and respect, and who hold them accountable if they were 
to relapse.  
Summary 
Participants in the present study discussed and shared a multitude of experiences 
and issues that they face on a regular basis when dealing with their need to use 
methadone to maintain their recovery. Data analysis resulted in five themes. These shared 
lived experiences or themes help broaden the understanding of the views, attitudes, and 
barriers for older methadone users. A discussion of study findings, limitations, 




Chapter 5: Discussion, Conclusions, and Recommendations 
The present study’s findings contribute to the understanding of the lived 
experiences of older methadone users addicted to various opiates and their thoughts about 
needing methadone. In this chapter, I summarize and expand on the results I presented in 
Chapter 4, discuss the findings in comparison to existing help for older methadone users 
in the literature review, examine the study’s strengths and limitations, and offer directions 
for further research based on data from this study. It is also my hope that findings from 
this study will stimulate positive social change by increasing the education of addiction 
professionals and funders who have a vested interest in creating relevant interventions for 
this particular population.  
The purpose of this phenomenological study was (a) to acquire an in-depth 
understanding of the phenomenon of older methadone users, (b) to elucidate and describe 
participants' experiences of addiction and treatment using their own voices and 
perspectives, (c) to extract and develop themes from the data, and (d) to interpret 
participants’ lived experiences and meaning constructions using a theoretical framework 
of addiction. This research study was conducted to address a gap in the literature on older 
methadone users, a population that has not been the subject of many studies. I hoped that 
findings generated from the study could inform therapeutic interventions designed to 
improve the treatment experience for older methadone users.   
Through this phenomenological study, the lived experiences or unique 
phenomenon of the treatment needs, views, and attitudes of older methadone users was 




respect was important and sometimes overlooked. The idea of decreasing their current 
methadone dosage was not identified as an issue that current treatment providers 
encouraged or felt older methadone users needed to consider. Instead, current dosage was 
valued and supported, although accessing actual care was more difficult for many reasons 
and rationales.  
Male and female participants all identified as being opiate dependent and needing 
methadone for their addiction but reported that they were not given the opportunity or 
social permission to be seen as having flaws. This failure on the parts of others to accept 
their defects did not prevent them from seeking out care but made it more difficult.   
In the fall of 2015, eight methadone users ages 50–55 years were recruited from 
the greater Grand Rapids, Michigan, area to participate in the present study. The 
participants agreed to share their stories about being on methadone at their age, their 
history of opiate addiction, and their treatment experience. As a result of extensive 
qualitative data analysis, five prominent themes materialized from the study. These 
themes were (a) relationships with others and the impact methadone has on these 
relationships, (b) attitudes of being an older methadone user, (c) mental health stressors 
related to being an older methadone user, (d) attending the methadone clinic daily, and 
(e) needing other treatment besides methadone to address their opiate addiction. Through 
these five themes, the lived experiences of older methadone users and their treatment 
needs, views, and attitudes about being an older methadone user were explained. Based 




meanings and interpretations that emerged from the data analysis process, answers to the 
research questions and a discussion of findings for each identified theme were as follows.  
Hermeneutic Reflection 
As the participants reflected on their lived experiences, their perceptions of what 
it means to be an older methadone user began to materialize and form. Interpreting the 
addicts’ productions of this enigmatic, socially constructed phenomenon, I observed that 
being an older methadone user means understanding and developing the need to rise 
above their previous hardships, which for study participants includes the challenge of 
trying to maintain their sobriety along with developing a normal life. Participants’ need 
for methadone and their disappointment in needing the medication have caused them 
mixed feelings about their current treatment. Having survived their addiction, the 
participants discovered the need to have others involved in their treatment experience 
recognizing they cannot remain sober on their own. The participants in this present study 
understood that their addiction has caused them problems in their lives and has also 
caused them to rethink their relationships with others.   
Research Questions and Answers 
This hermeneutic phenomenological study was guided by two main research 
questions and one subquestion:   
• RQ 1: What are the lived experiences of opiate users ages 50–55 years who take 
methadone to manage their addiction?  
• RQ 2: How do opiate users ages 50–55 years relate their particular experiences to 




• Subquestion: How do these same opiate users on methadone remain consistent in 
their methadone treatment so that they can stay in recovery?   
Research Question 1 
 
As the study findings illustrate, the participants ascribed meaning to their 
traumatic experiences regarding finding that they need methadone to have a life. The 
participants also indicated an increased dependency on others such as family and friends, 
a need to increase their self-worth and a need for personal growth, and a greater 
dependence on a treatment program. The most significant, compelling, and integrated 
meaning participants drew from their lived experiences is that their dependency on 
methadone was based on previous issues. In other words, the participants believed poor 
decision-making in the past had contributed to their dependency on methadone. As the 
accounts reflected in Theme 2 revealed, the participants’ lives became more 
consequential and focused through their telling others of their pain and suffering. 
Because of their live experiences, the majority of participants perceived that younger 
methadone users need to listen to them and understand the impact of their poor decision-
making.   
Research Question 2 
 
Based on the participants’ meaning-making constructions, the participants’ idea 
for needing recovery was the linchpin that held their unstable and complicated lives 
together. All participants endorsed the belief that recovery supports them during times of 
crisis and inflamed disturbance. The participants’accounts, the information indicated that 




Although their commitment to recovery was tested when participants were being 
tempted, they reported that once they began using methadone participants never lost sight 
of the importance of being in recovery. As Elizabeth stated, “Recovery saved my life and 
I would not be here if I had not begun to believe in it and work the methadone program.” 
Consequently, as the participants reflected on their lived experiences and as they gained 
awareness and perspective about recovery, their belief in the need for recovery grew 
stronger and more resilient.  
Follow-Up Question 
All participants acknowledged that despite their feelings about taking methadone, 
they do not miss an appointment. These participants stated that if they missed an 
appointment they could experience some physical and emotional withdrawal. These 
particpants also indicated that they would be expelled from the program and have to start 
all over again. Several participants expressed a desire not to have to attend the clinic 
every day. Some participants stated they wished there was a way to get the methadone 
treatment without going to the clinic daily. Anna stated that she felt chained to the clinic 
and could not spend time with others without having to report in. William indicated that 
he did not think the need to be involved in a recovery program is necessary for him to 
stay sober.  
For the most part, all study participants readily identified the importance of being 
in recovery at their age in at least some aspect. In light of their problematic lives, most 
participants found important meaning in being involved in recovery that includes 




belief of being in recovery to keep them from returning to previous behaviors that were 
problematic for them.    
One advantage that clinic attendance provides is consistency. According to 
Madden, Lea, Bath, and Winstock (2008) public clinics provide structured treatment that  
oversees the client’s dosing and access to medical staff and other support like case 
management, if needed. The negative of not attending the clinic daily is that there is no 
guarantee the participant will take the dosage as prescribed. Attendance offers structured 
treatment including supervised dosing and access to medical specialist and case 
management support. Takeaway doses are not dispensed routinely at most clinics and 
treatment is provided at no cost to the client.  
The concern is creating and sustaining medically dependent opiate users. Despite 
attending the clinic daily, the participants indicated that no one has discussed with them 
the idea of reducing their dosage after some time. Treatment providers are now being 
paid for the number of people they treat and may not consider transferring clients to other 
treatment providers, i.e., primary care physicians. Furthermore given the growing rate of 
opioid-dependent patients seeking psychosocial treatments there is a need to evaluate 
alternate interventions. 
Thematic Findings 
Theme 1: Methadone Impact on Participants’ Relationships With Others  
 
Study participants talked about how much their addiction has impacted their 
relationships with others. Several voiced disappointment and guilt about the effect their 




their guilt feelings than the men. Two female participants talked about feeling guilty 
about how their addiction forced them to eliminate any contact with their family and 
friends. These females acknowledged that they chose their opiates over their children and 
other family members.   
Another issue for study participants was trying to reestablish relationships with 
family and friends that had become strained due to their addiction. Several participants 
indicated that they have been working on trying to restore themselves with family and 
friends but that lack of trust interfered with that process. Seven participants indicated that 
it was important for older addicts to understand that their addiction impacts them and 
others as well.  
Similar to the previous research of Hamilton and Grella (2009), findings from the 
present study indicate that some older opiate addicts have regret and shame when it 
comes to their addiction and their relationships with others. Present findings showed 
some difference between genders in that male and female participants expressed similar 
feelings about the need to improve or reestablish family and social relationships. The 
women in the study indicated that they wanted to improve their relationship with their 
family members, while only two of the men acknowledged the same. Doukas (2011) 
noted that as addicts age, their immediate support system decreases as their family and 
friends move away or die. Many older addicts may isolate themselves from others due to 
their drug use thereby reducing their support system. Developing and keeping a healthy 
support system is important for anyone who is involved in substance abuse treatment, but 




Theme 2: Attitude of Being an Older Methadone User 
As reported in Chapter 4, study participants appeared to have mixed feelings 
about needing methadone at their age. Several of the women had a negative attitude about 
being on methadone at their age, while the men reflected a positive attitude. The female 
participants acknowledged trouble dealing with the stigma of being older methadone 
users. Some identified with issues of health, negative social relationships, and other 
stigmas associated with aging. Combined with needing methadone for their addiction, the 
participants reported feeling that society takes a dim view of them still needing support.    
One issue that was evident throughout the interviews was the participants’ 
concern about becoming addicted to methadone and having to experience withdrawal if 
they stopped taking it. Seven participants indicated that they were upset about starting 
methadone as they now are hooked on it like their opiates. These seven participants all 
agreed on the need to take methadone to help block and reduce the craving for illicit 
opiates. When asked what the chances of reducing their dosage were, six participants 
reported they did not feel they could for fear of physical and psychological withdrawal.   
One attitude participants expressed about being placed on methadone was 
treatment providers failing to inform potential clients of the risks of taking methadone. 
Two participants expressed concerns and anger about the lack of education provided to 
them regarding any problems with taking methadone. Four participants stated that they 
did not realize that they would need to take methadone for as long as they have been 




inform them that opiate addicts would need to take methadone for the rest of their lives 
and that their options were limited in treating their opiate addiction.  
Theme 3: Mental Health Stresses 
Mental health stressors and experiences related to being an older methadone user 
were prevalent in participant comments. Being an older methadone user was described as 
being stressful most of the time. Study participants could not stress enough the emotional 
and mental weight and burden that comes with needing methadone to feel safe and 
secure. Being on methadone at their ages was described as tiresome and, at times, a 
burden.  
Participants who have wanted to maintain a relationship with family members 
while using methadone needed to address mental health and stressful issues. These 
participants were not only responsible for maintaining their recovery but also felt a need 
to assure family members that they could be trusted to take care of finances, to be a good 
parent, and to ensure the family’s safety and welfare. Study participants identified the 
emotional swings they experienced on an average day. These participants acknowledged 
they could start their day thinking about getting to the clinic for their daily dosage and 
then worry about improving their relationships with others and improving their self-
esteem.  
Two of the women in this study expressed a need for mental health treatment to 
address past issues that were an impetus for their drug use. These issues were relationship 
problems, physical abuse, and feelings of rejection. One of the men in the study 




members of his family. He understood that even though he was the addict, his behavior 
had an impact on his wife and children.   
Although already dealing with the stigma of being an IV drug user, of aging, and 
of being on methadone treatment, many participants faced the stigma of mental illness. 
Like previous studies such as those made by Connor and Rosen (2008) and Semple, 
Grant, and Patterson (2005) regarding the stigma of mental illness, present study findings 
also showed that despite the need to address their mental issues, older methadone users 
were reluctant to talk to their family and friends about them. As previously stated, 
participants felt distinct pressure from family members to be perfect and not be affected 
by stress and life struggles in the same manner as those who are not addicts. Although the 
participants desired to be viewed as human, there was also pressure to maintain an image 
of being “healthy and fine.” This pressure made it difficult for participants to seek help, 
as they feared that they would return to their previous drug use behavior if they failed.  
Study participants made it clear that mental health treatment is important and a 
needed part of good self-care if older opiate users are to operate in a healthy manner 
when facing stressful situations. In talking about what qualities were most desirable in a 
therapist, participants wanted someone who had experienced addiction, relapse, and 
cravings. These qualities were approached from multiple perspectives. One participant 
compared the need for the therapist to understand cravings and other issues associated 
with being an addict with physicians who should be well educated in patients’ medical 
needs. Two participants commented on the need to know that the advice or guidance they 




(2010), the therapist’s approach for treatment in helping the addict develop a 
commitment to staying sober and being consistent with their treatment goals is vital to 
developing a strong alliance.  
Theme 4: Attending the Methadone Clinic Daily 
Unlike health policies in other countries, the United States does not have a 
specific policy regarding drug treatment service delivery. Many study participants 
supported the idea of obtaining their medication without having to attend the clinic on a 
daily basis. Similar to previous study findings of Treloar, Fraser, and Valentine (2007), 
participants indicated the benefits to them would be greater convenience, saving money 
on travel, reducing the possibility of others learning about their involvement, and 
increasing the ability to work. When starting a methadone treatment program, clients new 
to the procedure are expected to come to the clinic on a daily basis to secure their 
medication. One concern acknowledged by present study participants was the difficulty 
in getting to the clinic on a daily basis. Participants’ feelings appear to be supported by 
previous study findings that programs requiring long-term commitments for daily clinic 
attendance had difficulty retaining clients in treatment (Bell, Dru, Fisher, Levit, & Safraz, 
2002).  
Six participants expressed frustration about having to go to the clinic daily. The 
majority of participants felt that attending the clinic daily reflected a lack of trust in them. 
When asked about the possibility of relapsing, participants indicated that they would be 
more than willing to take a drug test to ensure that they are not using illicit drugs such as 




should she violate her agreement not to use illegal or illicit drugs.  It should be noted that 
urine drug tests will identify methadone as an opiate, but not an increase level of the 
opiates. Participants’ responses regarding service delivery and the clinic environment 
reflected a strong desire for having flexibility in going to the clinic and receiving their 
dosage as well as in clinic hours of operation. Their concerns were similar to those in 
other research regarding methadone treatment (Madden, Lea, Bath, & Winstock, 2008). 
Study participants seemed acutely aware of how clinic workers and others 
perceived their desire not to attend the clinic on a daily basis. Participants expressed 
concern that they did not always make the best decisions when it came to ensuring their 
methadone use. Participants shared stories of how some older users who were allowed to 
take their medication unsupervised did not always comply with the rules thereby forcing 
the clinic and others to reevaluate the takeaway program. A major theme derived from 
study participants when it came to not attending the clinic on a daily basis was trying to 
facilitate a normal lifestyle and generate a sense of trust in society.   
Theme 5: Needing Other Treatment Besides Methadone  
 
Needing other treatment besides methadone was an issue many study participants 
expressed throughout their narratives. Not lost on the participants was the need for 
additional treatment services not only for them at their age, but also for younger opiate 
addicts. Several women talked about their depression and its impact on their addiction. 
These women noted that they needed additional services to combat their depression so 
they would not seek drugs to treat their former ways of addressing their depression. 




opiate users have experienced. Six participants reported not being able to work to support 
themselves and experiencing some depression due to the loss of friends and associates. 
Although all of the participants felt that methadone was helping them with their cravings, 
three participants indicated that eliminating their cravings would help them not overdose 
like the friends they lost due to their friends’ addiction. Present study findings related to 
other issues besides participants’ addiction were similar to previous research related to 
co-occurring issues. Minkoff and Cline (2006) noted that when treating people with 
addiction and a mental health disorder, both should be treated at the simultaneously and 
each one given equal importance.    
Participants also discussed needing additional help with medical issues. Research 
has shown that medical professionals who work with people with addiction need to be 
trained to work with older opiate users who may be presenting with issues besides 
addiction (Doukas, 2011; Williamson, Darke, Ross, & Teesson, 2009). All four women in 
the present study admitted having some physical problems, and two of the women needed 
assistance for their mobility. These women reported due to their addiction they forfeited 
nutritional needs, failed to seek medical attention when feeling ill, or utilized prevention 
services such as flu shots or other vaccination as they were engaging in drug seeking 
behavior.  Two of the men stated that they had experienced some physical problems but 
had not sought medical attention. All participants noted that it was difficult for them to 
see a doctor on a regular basis, as all of the primary care physicians in the area limited the 




In the present study, seven participants reported being involved in an NA 
program. The particapnts’ reasons for being involved included the support the 
participants received from other addicts. Etheridge, Hubbard, Anderson, Craddock, and 
Flynn (1997) noted that the increase in NA meeting involvement is due in part to others 
understanding the importance of aftercare programs and a decrease in funding for 
treatment programs. Despite the 40 years of research on 12-step programs (White at al. 
(2013) stated treatment providers should not view 12-step programs as a standalone 
treatment.   
One issue in the present study that appeared to be similar to those in other studies 
was the lack of connecting with a sponsor. Only one participant indicated having a 
sponsor or someone in a program to talk to. Five participants stated that the reason for not 
having a sponsor was more about trust than availability. Concerns about confidentiality 
made it difficult for the participants to seek help as they felt a sponsor would, 
intentionally or not, share what was said. One participant valued being able to go to 
therapy in a place where he would not be seen by many people because of the premium 
he puts on privacy. If participants are involved in a 12-step program, other treatment 
modalities should also be such as outpatient methadone (OMT) and outpatient drug-free 
(ODF) programs should be included in their treatment plan. 
Another issue participants noted was dealing with some negative experiences at 
NA or AA meetings. Five participants talked about how some 12-step program 
participants, especially those in AA, saw people taking methadone as substituting one 




caring for themselves.  Although greater 12 step attendance was related to better 
treatment outcomes after detoxification, patient attendance and involvement in these 
groups did not lead to better opiate use outcomes. Consequently, an important goal of 
psychotherapy should be to encourage and maintain NA involvement. However, simply 
supporting a psychotherapy patient’s participation in NA fails to result in a unified 
treatment approach if the two models of change are not working together in a coordinated 
manner.  
Limitations of the Study 
The present study’s primary strength was its design. The help-seeking views, 
attitudes, and barriers for older methadone users are areas that have not received much 
research attention. This lack of information influenced the decision to use an empirical 
phenomenological framework to better understand the lived experiences of older 
methadone users. This form of qualitative research allowed for collecting data through an 
initial interview. By conducting in-depth interviews, I built rapport with the participants. 
This rapport was conducive to creating an environment of respect and safety that led to 
participants sharing deeply personal and revealing information.   
Additional study strengths included (a) bracketing of my experiences as growing 
up in an addictive family, (b) being an addiction therapist, (c) manageable sample size, 
which allowed for greater depth and broader scope of data retrieval, (d) an even 
distribution of men and women, which allowed for varying perspectives, (e) the age 
range of the participants in that they were all close in age and therefore able to identify 




minimize researcher bias and allow for participants to explore their experiences as they 
saw fit, and (g) a comprehensive analysis.  
With this said, it is important to note that results from the present study should be 
weighed against several limitations that are typical of qualitative research. First, the 
results may not be generalized to larger populations of older methadone users as my 
focus was only on elucidating and describing the lived experiences of the eight study 
participants. Second, all participants in the study came from the greater Grand Rapids, 
Michigan area, and all but one attended the same methadone clinic. Such similarity could 
impact the study as those attending the same clinic may have similar responses to all of 
the questions.  
Third, the sample was fairly homogeneous in that all of the participants were 
White despite efforts to recruit African Americans and other minorities who would also 
identify as being older methadone users. Therefore, the results may not be representative 
of members of a more diverse ethnic or racial groups. To recruit African Americans and 
other minorities, Spence and Oltmanns (2011) suggested that the advertisement seeking 
participants should be very specific as a general announcement may be viewed with 
skepticism in a minority community. Another way to help recruit minorities for future 
studies is that older African American should be addressed by their surname until the 
researcher is given permission to call the potential participant by their first name. Such 
behavior shows respect and sincerity in the African American community. Fourth, the 
information gathered for this study was obtained by conducting in-depth interviews and 




substantiate their stories or any empirical data as this type of information gathering was 
beyond the present study’s scope. I relied on each participant to be truthful about his or 
her experience as an older methadone user. Even knowing that they were to receive a 
small token of appreciation, all participants appeared surprised and appreciative when 
they received it.  
Research Recommendations 
Based on the present study’s strengths and limitations, some recommendations are 
proposed for future research. First, additional phenomenological studies should be 
conducted to examine the lived experiences of older methadone users. As discussed in 
Chapter 2, there is a significant gap in the qualitative literature about the experiences of 
older opiate users who depend on methadone for their addiction treatment. At the same 
time, methadone continues to be the primary treatment for opiate-addicted people, and 
the number of people needing methadone is on the rise (Bart, 2012; Gossop & Moos, 
2008).   
Second, while some quantitative studies have been conducted over the past 
several years on methadone use and addiction, very few phenomenological studies have 
been conducted to specifically examine older methadone users. Moreover, relatively few 
qualitative studies have been conducted regarding older methadone users needing to 
attend the methadone clinic and how not wanting to attend the clinic daily influences 
their methadone treatment. Generally speaking, more researchers should examine the 




taking their medication and how the medication impacts their treatment experience 
(Anstice et al., 2009).  
Third, future research on the lived experiences of older methadone users should 
focus on examining how various mental health diagnoses, family relationships, and legal 
status correlates with the treatment modality. Researchers should consider different 
coping strategies older methadone users engage in, including NA meetings, spirituality, 
and religious involvement. Although all present study participants acknowledged the 
importance of having a higher power, none indicated being involved in a specific 
religion. Furthermore, research should be conducted on this population’s help-seeking 
behaviors. Studies conducted over the past several years have shown that older 
methadone users experience some significant losses and exhibit a high degree of anxiety, 
low self-esteem, and a feeling of hopelessness (Borelli, Luthar, & Suchman, 2010; Gil-
Rivas et al., 2009; Kwiatkowski & Booth, 2003; Wu & Blazer, 2011).   
Fourth, research in this area would benefit from a larger study that sampled more 
participants and reflected a better racial balance. As previously mentioned, efforts were 
made to include African Americans in the present study, but this was not accomplished.  
African Americans are reluctant to be in an empirical research due to not trusting 
research based on past negative experiences (Coker, Huang, & Kashubeck-West, 2009; 
Katz et al., 2009). Generally speaking, African Americans tend not to trust outsiders as 
there is a shroud of secrecy regarding the African American culture (Nicolaidis et al., 





A larger study would potentially allow for more themes under the views domain 
to be flushed out and explored, which would further impact how clinicians understand 
and work with older methadone users. A larger study would also allow for further 
exploration of issues such as confidentiality in the community and in the clinical 
relationship. Finally, a larger study would also potentially carve a well-rounded depiction 
of the preferred characteristics of clinicians who work with this population. From a larger 
study, a treatment model could be developed through a qualitative grounded theory 
framework. As older methadone users are better understood in their cultural context, a 
model that addresses and understands older methadone in that context could prove 
monumental. Older methadone users must deal with the reality of being an opiate addict 
in the addiction community as well as individuals unable to share their stories with 
others. This unique intersection requires sensitivity to ethnic, spiritual, and cultural 
issues. A model in which it were possible to juxtapose these key identity factors for this 
population would be a model with the power for addressing stigma and making mental 
treatment more accessible and welcoming to older methadone users.    
A study on the impact of good mental health care and wellness in older 
methadone users and how these factors influence the mental health and emotional 
wellness of their families, especially their children, would be powerful. Many participants 
in the present study shared concerns about how their addiction had affected their 
relationships with family members and how their children have engaged in some drug use 




family members may impact older methadone users’ decisions to seek help if they 
believed that it would impact their family in a positive manner.  
Implications for Social Change 
Some important implications emanated from the present study's findings related 
to research methodology, the practice of professional counseling, and engendering 
positive social change at the micro- and macrosocietal levels. Regarding methodology, 
results from the present study add to the knowledge base of qualitative research 
concerning older methadone user. This study was undertaken, in part, because a 
significant gap existed in the qualitative literature about dosage and the need for daily 
clinic attendance for older methadone users in the United States. The majority of the 
research I identified in Chapter 2 was done in Europe or Australia.   
To date, few phenomenological studies have been conducted on the lived 
experiences of older methadone users in general and the lack of ongoing treatment 
outside of the daily dosage they receive. Moreover, the intrapsychic and sociocultural 
factors impacting low-income older methadone users have not been closely examined 
from a hermeneutical phenomenological standpoint. Even community gatekeepers tend to 
be leery of empirical research endeavors, especially where vulnerable populations are 
concerned. For instance, before launching this study, I attempted to gain access to two 
major methadone treatment clinics by visiting and talking about the study to the program 
directors. Neither was willing to help recruit participants and felt the study was 
unnecessary. Despite these roadblocks, I forged ahead and employed a mass marketing 




Findings from this study further convey implications for professionals working 
with older methadone users. Professionals involved with addiction treatment, particularly 
methadone, may use this study’s results to develop appropriate treatment interventions 
for this population. Although much of previous research about methadone maintenance 
treatment focused on dosing and illegal drug use, it is important for treatment providers 
to understand how to incorporate various treatment modalities for an older population 
dependent on various medications. Findings from the present study validated prior 
research findings indicating that older methadone users will need a variety of services to 
help ensure they maintain their sobriety and do not return to previous negative behaviors.   
In the same vein, findings from the present study can potentially create positive 
social change for older methadone users who fail to grasp the need for additional services 
and may fall victim to not engaging in other treatment. Collaboration is needed between 
treatment providers, funders, and the addiction community so that positive social change 
for individuals on methadone may help reduce relapses, criminal justice system 
involvement, and increase medical interventions among older methadone users. On an 
organizational level, an ongoing working collaboration between treatment programs and 
the addiction community may result in service delivery improvement and increase 
knowledge regarding stages of change. Finally, relationships between older methadone 
users and treatment providers can potentially increase utilization of other services such as 
employment and education counseling as well as others as a well-informed provider may 





This hermeneutic phenomenological study’s focus was on examining the lives of 
eight methadone users ages 50–55 years who use methadone to address their dependency 
on various opiates. These participants shared their private stories and viewpoints for this 
study and discussed the issues that caused them to need methadone at their age.  Findings 
from this study demonstrated that as this population ages there is a need for collaboration 
between service providers as older methadone users will need additional services to have 
a healthy life. Researchers to date have not adequately studied this population’s 
experience in using other treatment modalities besides methadone and the outcomes of 
those who have. Study findings showed that older methadone users have unique lived 
experiences as they deal with views, attitudes, and barriers in maintaining their sobriety 
that need to be further explored and addressed if the field of addiction treatment hopes to 
provide quality and relevant care to all those who need such care and seek it out. It was 
my goal to provide a different perspective for service providers by giving a voice to older 
methadone users.  
In spite of life's challenges, study participants have embarked on rebuilding and 
reinventing themselves as older methadone users. Taking their recovery slowly, the 
participants are progressively redefining their personal values; participants do not want to 
review any negative ideas from their past experiences or other people’s beliefs of who 
they are or what they should be. Because of their renewed faith in themselves, study 




do for them. From their lived experiences, participants will hopefully take lessons learned 
with them and try to help others understand methadone’s long-term effects.    
As agents of social change, counselors and other human service practitioners must 
find ways to develop culturally relevant interventions to help older methadone users 
continue to make transformative and meaningful changes in their lives. Hopefully, 
findings cultivated from the present study will add to the body of knowledge that informs 
professional counselors in facilitating the process of growth and change for individuals’ 
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Appendix A: Advertisement for Potential Participants 
 
Advertisement for Potential Participants 
Let your voice be heard! 
Could you be a potential participant dissertation research study? 
 
Who is conducting the study? 
 
LaMart Hightower, a Ph.D. candidate at Walden University for the completion of his 
academic work. This facility is not conducting the study and is not responsible for 
questions asked, the collection of the material, or its dissemination.  
What is the purpose of this study? 
The purpose of this study is to assess the relationship between methadone maintenance 
and the life experiences of older opiate users, those 50 to 55 years old. 
Who is needed for this study? 
• Acknowledge a history of opiate dependency 
• Are between 50 and 55 years old 
• Are currently on methadone to treat their addiction to opiates 
• Have been involved in a license methadone treatment program for the past two       
years 






In order to CONFIDENTIALLY find out more about this study and possible become a 
participant, please email me at lamart.hightower@waldenu.edu or call me at 616-304-
0149 with your contact information and your preferred means of communication and I 

























Appendix B: Demographic Data Questionnaire  
 
 
Demographic Data Questionnaire 
 
The title of this study is A hermeneutic phenomenology examination of methadone 
treatment and relapse by opiate dependent addicts 50 years and older. 
Please complete each of the following demographic items. Thank you for your 
participation. 
 




2. Age at last birthday________ 
 
3. Marital Status (Please check one) 
 
Married____ Divorced____   Widowed____    Single____ 
 
4. Please check one 
 
White______   Black or African American____ Hispanic_______ 
 
Asian American_________ Other_____ (please specify) ___________________ 
 
5. Highest educational level completed (Please check one) 
 
Grade School____    High School____    Some College____ 
 
College Graduate____    Graduate or Professional School____ 
 
6. As of 2015, how many years have you been on methadone? ________ 
 
7. Are you taking methadone to treat an addiction to opiates? Yes_____   No____ 
 
8. How long have you been in recovery from opiates? _____________ 
 
9.  Are you taking methadone for pain management?  Yes___   No____ 
 





Yes____     No____ 
 
If yes, please identify which treatment (check all that apply) 
 
Residential_____   IOP______ Outpatient______   NA/AA______   Other______ 
 
During the time of your sobriety how much of the time have you had any of the 
following problems with your work or regular daily activities as a result of your 
addiction (such as feeling depressed or anxious)? 
 















11.  Has your health declined in the 
past 











13. Did activities decrease  
  
 
14.  During the past year to what extent has your addiction interfered with your 
normal social activities with family, friends, neighbors, or groups? 
 
 Not at all  Slightly  Moderately  Quite a bit  Extremely 
 
15. Describe your cravings for opiates have you had in the past year?  
 










      
 
16. During the past year how much has your addiction interfere with your normal life 
(including both work outside the home and housework)? 
 





These questions are about how you feel and how things have been with you 
during the past year.  For each question, please give the one answer that comes 


















17. How often has your 





     
18. Do you have difficulty 
making appointments?  
 
     
19. Do feel like your friends 
and family have been 
supportive of your 
treatment? 
 
20. Have you thought about 
using another medical 
assisted treatment other 
than methadone?                      
     
 
     
 
      
21. During the past year how 
much has your addiction 
interfered with your social 
activities (like visiting 
friends, relatives, etc.)? 
 
     
22. Do you feel like your 
treatment plan is working 
for you?  
     
      
      




Appendix C: Informed Consent 
Informed Consent Form 
 
A hermeneutic phenomenological study of methadone treatment by opiate dependent 
addicts 50 years and older. 
Walden University 
 You are participating in a research study of opiate users who are maintaining their 
recovery with the use of methadone. You are being asked to participate because you met 
the inclusion criteria for this study. The inclusion criteria are male or female, between the 
ages of 50 to 55 who are involved in a methadone clinic; have been taking methadone for 
at least two years; and reside in one of three counties in the state of Michigan, Kent, 
Muskegon, and Wayne.  Please read this form and ask any questions you may have 
before signing this consent form.   
 This study is being conducted by LaMart Hightower (a PhD candidate at Walden 
University). 
Background Information: 
 This study is important in the field of addiction as it increases the understanding 
of older opiate users and their lives such as family, medical issues, legal issues, and 
relationships. This study will help promote changes through improved understanding of 
methadone use for substance abuse therapists.   
Procedure: 
 If you are interested in being in this study, please complete the attached 




meet the inclusion criteria, you will participate in an open ended interview which will last 
between 60 to 90 minutes.  The interview will be audio taped.  The researcher will ask 
questions regarding your life while using methadone.  If you are unsure of the question, 
you may ask for clarification or indicate your refusal to answer any questions. Once the 
researcher has completed asking you questions, you will be given an opportunity to ask 
any questions of your own.  If the researcher feels there is a need for follow up questions, 
he will inform you of this prior to your leaving and decide on the best way to 
communicate such request.  The researcher will thank you for your time and discontinue 
the recording.  It is important to note that you must sign the consent form before the 
research can begin to ask any questions.  
Voluntary Nature of the Study: 
 Your participation in this study is strictly voluntary. Your decision whether or not 
to participate will not affect your current or future relationship with anyone. If you 
initially decide to participate, you are still free to withdraw at any time without affecting 
those relationships. 
Risks and Benefits of Being in the Study: 
 In the event you begin to experience stress or possible relapse issues, you may 
terminate your participation at any time.  You may also refuse to answer any questions 
you consider invasive or stressful. In addition, I will provide you with a referral for 
services in your community if you began to experience undue stress.  In Muskegon 
County this will be a referral to Lakeshore Coordinating Agency, Kent County, this will 




Wayne Mental Health Authority.  These places will offer a free evaluation and referral to 
appropriate treatment programs.    
 The benefit of participating in this study is to expand information available 
regarding opiate dependency, with an emphasis on methadone use among older opiate 
users. 
Compensation: 
 Those who are interviewed will receive a $20.00 gift card from Walmart.  
Confidentiality: 
 In order to ensure the confidentiality of the participants only the primary 
researcher will know the identities of each of the participants.  Each participant will be 
given a pseudonym to disguise his or her identity.  All paperwork regarding the 
participants will be stored in a locked file cabinet that only the primary researcher will 
have access to.  The researcher will be sure to describe the sample in detail in the 
beginning of the study and information pertaining to a particular participant will not have 
any identifying information attached to it. All direct quotes that will be used will be 
shown to that participant prior to them being included in the study to ensure that the 
participant is comfortable with the wording and to give him or her an opportunity to 
modify the statement to provide them with sufficient anonymity.  
 Each of the participants in the study will be given pseudonyms (for example 
Participant #1) to prevent identification in reports or results.  The key to the match of 
pseudonyms and the participant’s real names will be kept at the researcher’s office in a 




collected throughout the study and will be separated from any of the data collected.  
Likewise, recorded data will be kept in a locked filed cabinet and transcripts will also be 
kept separate in a locked file cabinet.  University regulations also require that the 
principal investigator keep copies of the participant list separate from transcribed data at 
his office in a locked file cabinet.  The audio recordings of the interviews will be erased 
from the voice recorder after the transcripts are completed and checked for accuracy.  Per 
Walden University’s policy I will maintain all information in a locked file cabinet for five 
years after the completion of the study.   
I also am aware that the researcher is a mandated reported in the state of Michigan 
and is required to report specific incidents to the appropriate authorities. These 
incidents include information that may indicate current child abuse or neglect; current 
abuse of a vulnerable adult; and/or indications that I am at risk of harming myself or 
others.   
Contacts and Questions: 
 The researcher for this study is LaMart Hightower. The researcher’s advisor is Dr. 
Barbara Benoliel. You may ask any questions you have now.  If you have questions at a 
later date, you may contact LaMart Hightower at (616) 304-0149 or email 
lamart.hightower@waldenu.edu. The Research Participant Advocate at Walden 
University is Dr. Leilani Endicott and you may contact her at 612-312-1210 if you have 
any questions about your participation in this study.  
You may keep a copy of this consent form. 




Statement of Consent: 
  I have asked questions and have received the answers.  I have read the above 
information and I agree to participate in the study.  
Printed Name of the Participant: 
 
_________________________________      _____ 
Signature          Date 
 
 
_________________________________      ______ 




Appendix D: Script for Recruitment to Participate in In-Depth Interview 
 
Script for Recruitment to Participate in In-Depth Interview 
(This script is to be used when meeting with the participant face to face prior to the 
interview.  
Hello my name is LaMart Hightower. Thank you for your willingness to participate in 
my dissertation study entitled “A hermeneutic phenomenological study of methadone 
treatment for opiate dependent addicts 50 to 55 years old.” 
As you may recall, the purpose of this study is to gain insight into the lives of people 50 
to 55 years old who are using methadone to treat their addiction to opiates.   The ultimate 
goal is to expand on existing help-seeking literature by using yours and other 
participants’ experiences and worldviews to shed light on the lived experiences of older 
methadone users as it relates to treating their addiction, responding to additional needs, 
and understanding the role methadone plays in their lives. 
The format of the individual interview is a conversational manner where you would 
respond to open-ended questions, describe your experiences, and include your thoughts 
and opinions concerning methadone use, your history of addiction, seeking other 
assistance, and other issues regarding your recovery. 
Once I have completed all initial individual interviews and analyzed them, you and other 
participants may be asked to participate in a follow-up interview. The open-ended 
questions that will guide the follow-up interview will be developed based on yours and 




All the information collected from you is confidential. Your name or any other 
identifying information will not be used in any analysis or in any reporting of the data. 
Your participation in this research is completely voluntary. You may decide not to 
participate, to withdraw at any time during the interview, or not to answer certain 
questions without prejudice or penalty. 
May I answer any questions you have? 
 
Thank the participant. 
 
 
 
 
 
 
 
 
 
 
